The Indianapolis City Council last night approved a measure that will ban smoking in restaurants, except for those establishments which decide not to serve youths (under age 18). Bars are also excluded from the ban, as long as they serve only adults. The measure represents a compromise from an earlier and stronger ordinance that did not include the exemption for adult-only establishments, but did not have enough support to pass the Council. Public health groups apparently supported the amended ordinance and celebrated its passage.
The Rest of the Story
I don't see much to celebrate here; in fact, I think there is reason for grave concern among public health advocates in Indiana and nationally. This measure makes no advances in occupational health protection for bar and restaurant workers in Indiana, and does not even really improve public health protection for restaurant patrons.
Think of it this way: Prior to the ordinance, customers could choose whether they wanted to go out to eat at a smoke-free restaurant or not. Their choice of establishments was dictated by the decision of the establishments about whether to allow smoking or not. After the ordinance, customers will still be able to choose whether they want to go out to eat at a smoke-free restaurant or not. Their choice of establishments will be dictated by the decision of the establishments about whether to allow children or not. Thus, the ordinance does not guarantee any improvement in protection from the alleged hazards of secondhand smoke; in fact, if enough restaurants choose to become adult-only establishments, the number of smoke-free restaurants in Indianapolis could actually decrease. I don't think it will - but that's not the point. The point is that the law itself offers no public health protection for restaurant patrons. I do not think it is justified on a public health basis.
What about restaurant workers? Prior to the ordinance, workers had no choice whether they would be protected from secondhand smoke exposure on the job. Their exposure was determined by the decision of their restaurant's management. After the ordinance, workers will still have no choice whether they will be protected from secondhand smoke on the job. Their exposure will still be determined by the decision of their restaurant's management. The bill clearly offers no guarantee of protection for restaurant workers, and for those who are unfortunate enough to work in adult-only establishments, levels of carcinogens in their work environments will likely increase, as smokers shift over to frequent these establishments more often. The ordinance clearly has no public health justification on occupational health grounds.
So the rest of the story reveals that what we actually have here is a measure enacted in the name of protecting the public's health which has no public health justification, which offers no guaranteed public health protection to anyone - customers or workers - and which will likely result in markedly increased exposure to secondhand smoke for a large group of workers: those employed in establishments that are, or decide to become, adult-only restaurants or bars.
Even worse, the fact that the largest city in Indiana has now passed such a measure will serve as a model and a precedent for other communities in Indiana (and throughout the country) to follow. Now, politicians throughout the state know that you can please public health advocates in Indiana by just making sure kids are not exposed to secondhand smoke in restaurants. There is no need to feel any political pressure to protect people from secondhand smoke.
This completely undermines the national clean indoor air movement, by framing secondhand smoke as a hazard only insofar as it potentially affects the health and/or comfort of kids. Adult exposure is apparently not a problem or at least not enough of a problem that public health practitioners insist that something be done about it. By inference, I guess the health hazards of secondhand smoke must not be too severe. Otherwise, one wouldn't expect public health advocates to be treating this only as a kids issue. And it certainly is no longer going to be viewed as an issue of occupational health, since workers are completely left out of the scope of health protection. In fact, the situation will likely become much worse for a sizable proportion of Indianapolis bar and restaurant workers.
The legacy of Georgia's SB90 has officially begun. Whether the Georgia compromise had any effect on lawmakers in Indianapolis I don't know. But in any case, the combination of these two precedent-setting moves is sure to persuade policy makers in other cities and states that protecting kids is good enough for the anti-smoking groups. The clean indoor air movement in this country has suffered two devastating blows.
Tuesday, May 24, 2005
Monday, May 23, 2005
The Ultimate Unlevel Playing Field: Florida Legislature Approves Smoking Ban Exemption for One Restaurant
The Florida legislature has passed a bill that expands the exemption of certain restaurants from the statewide restaurant smoking ban that was approved by Florida voters in 2002. That statewide initiative bans smoking in restaurants, but excludes stand-alone bars, which are defined as establishments that derive no more than 10% of their revenues from the sale of food. Senate Bill 1348, passed by the legislature on May 5, expands this exemption to certain establishments that derive up to 20% of their revenues from the sale of food.
The Rest of the Story
What are the "certain establishments" that the bill allows to derive up to 20% of their revenues from the sale of food and still be exempt from the smoking ban? The answer is quite simple: establishments that are listed on the National Register of Historic Places, and which had applied to be on this register no later than 90 days following the effective date of the legislation.
Why this seemingly crazy legislation? The answer is apparently quite simple: to provide an exemption from the smoking ban for a single establishment - Sloppy Joe's of Key West - a restaurant/bar in a historic district which derives 17% of its revenues from the sale of food and is thus subject to the current smoking ban - but which, lo and behold, has just applied to be listed on the National Register of Historic Places!
While I have argued previously that from a public health perspective, it is important to promote a level playing field such that workers at all establishments are treated equally in terms of health protection, this is far beyond even the unlevel playing field that I had envisioned. The idea of a state legislature, which is entrusted with protecting the health and welfare of the entire citizenry of the state, enacting a measure to exempt a single establishment from a statewide public health law is not only irresponsible but absurd.
The measure awaits Governor Jeb Bush's signature or veto. There are some indications that he may veto the bill, as he apparently indicated that he finds the exemption for a single restaurant to be inappropriate. And the legislature is unlikely to override any veto, since the House only approved the bill by a 60-50 vote. However, the damage has already been done. The bill sends a message to bars and restaurants throughout the state that the legislature is ready and willing to provide exemptions, so long as you have the right contacts and the right political clout.
While this story will likely simply go down as a crazy anecdote in legislative history, it should send an important message to public health advocates. We must make it clear that health protections are to be applied to all employees and all establishments equally. We must not, ourselves, be in the business of promoting exemptions for certain types of facilities. Doing so sets a terrible example that legislators are sure to pick up on. What is needed and appropriate is a level playing field that provides adequate health protection for all workers.
This story underscores the folly of Georgia health groups' decision to support the recently enacted legislation that exempts adult-only restaurants from the state's clean indoor air law and which allows an additional exemption for separately ventilated smoking rooms in restaurants. That decision is going to backfire in the long run. For I'm afraid it sets an example that other states will follow. It sends a message that public health advocates are fine with the idea of setting an unlevel playing field that exempts certain establishments. As long as you're on the long end of the stick in this political game, your restaurant can end up allowing smoking. Health regulation becomes a political game, rather than a matter of principle.
The Rest of the Story
What are the "certain establishments" that the bill allows to derive up to 20% of their revenues from the sale of food and still be exempt from the smoking ban? The answer is quite simple: establishments that are listed on the National Register of Historic Places, and which had applied to be on this register no later than 90 days following the effective date of the legislation.
Why this seemingly crazy legislation? The answer is apparently quite simple: to provide an exemption from the smoking ban for a single establishment - Sloppy Joe's of Key West - a restaurant/bar in a historic district which derives 17% of its revenues from the sale of food and is thus subject to the current smoking ban - but which, lo and behold, has just applied to be listed on the National Register of Historic Places!
While I have argued previously that from a public health perspective, it is important to promote a level playing field such that workers at all establishments are treated equally in terms of health protection, this is far beyond even the unlevel playing field that I had envisioned. The idea of a state legislature, which is entrusted with protecting the health and welfare of the entire citizenry of the state, enacting a measure to exempt a single establishment from a statewide public health law is not only irresponsible but absurd.
The measure awaits Governor Jeb Bush's signature or veto. There are some indications that he may veto the bill, as he apparently indicated that he finds the exemption for a single restaurant to be inappropriate. And the legislature is unlikely to override any veto, since the House only approved the bill by a 60-50 vote. However, the damage has already been done. The bill sends a message to bars and restaurants throughout the state that the legislature is ready and willing to provide exemptions, so long as you have the right contacts and the right political clout.
While this story will likely simply go down as a crazy anecdote in legislative history, it should send an important message to public health advocates. We must make it clear that health protections are to be applied to all employees and all establishments equally. We must not, ourselves, be in the business of promoting exemptions for certain types of facilities. Doing so sets a terrible example that legislators are sure to pick up on. What is needed and appropriate is a level playing field that provides adequate health protection for all workers.
This story underscores the folly of Georgia health groups' decision to support the recently enacted legislation that exempts adult-only restaurants from the state's clean indoor air law and which allows an additional exemption for separately ventilated smoking rooms in restaurants. That decision is going to backfire in the long run. For I'm afraid it sets an example that other states will follow. It sends a message that public health advocates are fine with the idea of setting an unlevel playing field that exempts certain establishments. As long as you're on the long end of the stick in this political game, your restaurant can end up allowing smoking. Health regulation becomes a political game, rather than a matter of principle.
DOJ Case Ends with Request for Multi-Billion Dollar Smoking Cessation Program
The Justice Department last week concluded its testimony regarding potential remedies in its RICO case against the tobacco companies by requesting that the companies be required to fund a $5.2 billion per year national smoking cessation program. The program would include "$3.2 billion annually for quit lines and medications, a $1 billion per year media campaign and another $1 billion per year in research and training." The total cost, over 25 years, would come to $130 billion.
The Rest of the Story
While a national smoking cessation program would be of great public health benefit, I do not think that forcing the companies to fund smoking cessation programs is consistent with section 18 U.S.C. section 1964(a) (the civil remedies provision of the RICO statute) and is therefore not likely to be upheld by the Appeals Court. I do not see how funding a smoking cessation program has anything to do with changing tobacco company conduct with regard to the alleged RICO violations. Such a remedy appears to be aimed at "remedying the effects of past conduct to restore the status quo," exactly what the Appeals Court ruled was not permissible under RICO. It's not clear to me how forcing the companies to fund smoking cessation would help prevent and restrain future RICO violations. I have presented an in depth discussion of this issue previously.
I see two meaningful remedies that are likely to withstand Appeals Court scrutiny, as they are directly tied to the prevention of future RICO violations:
Since this plan establishes a financial incentive for cigarette companies not to market their products to youths, it can be argued that this remedy is forward-looking and aims to prevent future RICO violations. The potential problem is that youth smoking prevalence is a measure only indirectly tied to future RICO violations. There are a number of reasons why youth smoking prevalence targets may not be met, of which continued marketing to youths is only one. So it is unclear whether the D.C. Appeals Court would find this remedy to be consistent with 18 U.S.C. section 1964(a).
But other than directly establishing requirements for cigarette marketing and labeling, it is the only meaningful remedy (and the only monetary one) that I think has any chance to be upheld.
The Rest of the Story
While a national smoking cessation program would be of great public health benefit, I do not think that forcing the companies to fund smoking cessation programs is consistent with section 18 U.S.C. section 1964(a) (the civil remedies provision of the RICO statute) and is therefore not likely to be upheld by the Appeals Court. I do not see how funding a smoking cessation program has anything to do with changing tobacco company conduct with regard to the alleged RICO violations. Such a remedy appears to be aimed at "remedying the effects of past conduct to restore the status quo," exactly what the Appeals Court ruled was not permissible under RICO. It's not clear to me how forcing the companies to fund smoking cessation would help prevent and restrain future RICO violations. I have presented an in depth discussion of this issue previously.
I see two meaningful remedies that are likely to withstand Appeals Court scrutiny, as they are directly tied to the prevention of future RICO violations:
- requiring substantial changes in cigarette advertising and marketing, including measures to prevent the marketing of cigarettes to youths and to prevent certain deceptive aspects of the marketing, such as the potential health value of "light" and "low-tar" cigarettes; and
- requiring substantial changes in cigarette labeling and packaging, including larger, stronger, and more graphic warning labels.
Since this plan establishes a financial incentive for cigarette companies not to market their products to youths, it can be argued that this remedy is forward-looking and aims to prevent future RICO violations. The potential problem is that youth smoking prevalence is a measure only indirectly tied to future RICO violations. There are a number of reasons why youth smoking prevalence targets may not be met, of which continued marketing to youths is only one. So it is unclear whether the D.C. Appeals Court would find this remedy to be consistent with 18 U.S.C. section 1964(a).
But other than directly establishing requirements for cigarette marketing and labeling, it is the only meaningful remedy (and the only monetary one) that I think has any chance to be upheld.
Friday, May 20, 2005
Partners for Effective Tobacco Policy Coalition Sends Deceptive Letter to Congress
A coalition of medical and public health groups which calls itself "Partners for Effective Tobacco Policy" has sent a letter to members of Congress which purports to inform policy makers about the FDA tobacco legislation (H.R. 1376 and S. 666) that has been introduced into the 109th Congress. The letter, dated April 7, compares the authority that FDA would be given to regulate tobacco products with existing authority that the Agency has to ensure the safety of other products.
The coalition, which is headlined by the Campaign for Tobacco-Free Kids, the American Cancer Society, the American Lung Association, and the American Heart Association, also includes a number of other important groups which co-signed the letter, such as the American Public Health Association, American College of Preventive Medicine, Association of Teachers of Preventive Medicine, Society for Public Health Education, American College of Physicians, American College of Cardiology and the American College of Chest Physicians.
In comparing the authority that FDA would be given to regulate tobacco products with existing powers FDA has to regulate the safety of other products, the letter states that H.R. 1376/S. 666 provides "FDA with authority over tobacco products similar to the authority it has over other products. FDA would have the authority to stop tobacco marketing and sales to our children and to subject tobacco products to the same consumer protections, such as ingredient disclosure, product regulation and truthful packaging and advertising, applied to other products. Just as we entrust FDA with the authority to approve every ingredient in food to ensure safety, we should give FDA the same authority to regulate tobacco products."
The Rest of the Story
This letter is misleading and deceptive and will likely have the effect of providing members of Congress with an inaccurate understanding of the nature of the proposed legislation. Any organization that signed on to this letter having first read the text of the letter should be ashamed of itself and I think owes the public health community an apology. I also think that each organization and/or the Partners coalition itself is obligated to send a letter of clarification to our policy makers. I think the letter represents unethical public health conduct, and violates the basic code of public health ethics.
Why? Because the letter misrepresents the nature of the legislation in a profound way, and any professional medical or public health organization that read the letter should have been aware of this. Thus, signing on to the letter must be presumed to represent a willful (i.e., intentional) attempt to deceive policy makers about the true nature of the legislation.
The letter states that the legislation would provide FDA with authority over tobacco products that is "similar to the authority it has over other products." This is, frankly, a bunch of crap. In no way is the authority provided to FDA in this legislation similar to that provided to the Agency for the regulation of other products, such as food and drugs. In fact, it is fundamentally different.
If any of the organizations took the time to read the bill before signing on to the letter, they would have immediately had to notice the very first major provision of the legislation. Section 901(a), entitled "FDA Authority over Tobacco Products," reads: "Tobacco products shall be regulated by the Secretary under this chapter and shall not be subject to the provisions of chapter V." And what is chapter V? It is the entire regulatory authority for ensuring the safety of drugs and devices.
And the bill itself does not give FDA the major aspects of the authority it has over food and drugs.
Most importantly, it cannot remove a tobacco product from the market under any circumstances, even if it is deadly. In contrast, a drug or device can and must be immediately removed from the market if it is found to cause serious health consequences: "If the Secretary finds that there is a reasonable probability that a device intended for human use would cause serious, adverse health consequences or death, the Secretary shall issue an order requiring the appropriate person (including the manufacturers, importers, distributors, or retailers of the device) - (A) to immediately cease distribution of such device." [see 21 U.S.C. chapter IX, section 360(h)(e)(1)]
Unlike its authority over food additives, the Agency is not required to do anything about tobacco additives, even if such additives are known to be deadly. In contrast, food additives are not allowable unless "the proposed use of the food additive ... will be safe: Provided, That no additive shall be deemed to be safe if it is found to induce cancer when ingested by man or animal." [see 21 U.S.C. chapter IX, section 348(c)(3)(A)]
Unlike its authority over drugs, the Agency is not required to deem a tobacco product as being misbranded, and not allowable, if it is deadly if used as intended. In contrast, a drug is automatically deemed to be misbranded "if it is dangerous to health when used in the dosage or manner, or with the frequency or duration prescribed, recommended, or suggested in the labeling thereof." [see 21 U.S.C. chapter IX, section 352(j)]
Moreover, unlike its authority over drugs, the Agency is not allowed to establish a system by which adverse events related to the use of tobacco products are required to be reported. In contrast, chapter V sets up a system for "receiving reports of adverse events regarding drugs." [see 21 U.S.C. chapter IX, section 355b(a)]
As I think should be obvious, it is very clear that the FDA legislation does not give the Agency authority over tobacco products "similar to the authority it has over other products." In fact, the authority is about as different as one could imagine.
It is also clear that the legislation does not "subject tobacco products to the same consumer protections...applied to other products." This statement, in fact, comes dangerously close to being not just misleading, but grossly inaccurate.
And the statement that "Just as we entrust FDA with the authority to approve every ingredient in food to ensure safety, we should give FDA the same authority to regulate tobacco products" implies that the FDA legislation would give FDA authority to "approve every ingredient" in cigarettes, which is completely false.
In signing this letter, the organizations that make up the "Partners for Effective Tobacco Policy" have, I think, violated accepted standards of professional public health conduct that require public health organizations to provide the public with full and accurate information that is necessary to make decisions on policies. This is what the APHA Public Health Code of Ethics calls the "community-level" equivalent of the individual-level ethical principle of informed consent:
"Public health institutions should provide communities with the information they have that is needed for decisions on policies or programs and should obtain the community’s consent for their implementation. ... there is a moral obligation in some instances to share what is known. For example, active and informed participation in policy-making processes requires access to relevant information. ...Such processes depend upon an informed community. The information obtained by public health institutions is to be considered public property and made available to the public."
The letter has not only failed to inform members of Congress of the critical differences in the regulatory system that H.R. 1376/S. 666 sets up for tobacco products compared to FDA's authority over food and drugs, but even worse, it has completely misled them about these differences.
Note that I am not arguing here that the FDA legislation should necessarily give the Agency authority that is similar to its authority over food and drugs. Such a regulatory framework would most likely require tobacco products to be removed from the market. But the Partners' misrepresentation of the nature of FDA authority over tobacco products as provided by this legislation is inappropriate, irresponsible, and unethical.
I would certainly hope and expect to see a retraction and apology for this letter, either by the entire coalition as a whole, or by each of the 34 organizations that should feel ashamed for having taken part in such a deceptive and inappropriate lobbying endeavor.
The coalition, which is headlined by the Campaign for Tobacco-Free Kids, the American Cancer Society, the American Lung Association, and the American Heart Association, also includes a number of other important groups which co-signed the letter, such as the American Public Health Association, American College of Preventive Medicine, Association of Teachers of Preventive Medicine, Society for Public Health Education, American College of Physicians, American College of Cardiology and the American College of Chest Physicians.
In comparing the authority that FDA would be given to regulate tobacco products with existing powers FDA has to regulate the safety of other products, the letter states that H.R. 1376/S. 666 provides "FDA with authority over tobacco products similar to the authority it has over other products. FDA would have the authority to stop tobacco marketing and sales to our children and to subject tobacco products to the same consumer protections, such as ingredient disclosure, product regulation and truthful packaging and advertising, applied to other products. Just as we entrust FDA with the authority to approve every ingredient in food to ensure safety, we should give FDA the same authority to regulate tobacco products."
The Rest of the Story
This letter is misleading and deceptive and will likely have the effect of providing members of Congress with an inaccurate understanding of the nature of the proposed legislation. Any organization that signed on to this letter having first read the text of the letter should be ashamed of itself and I think owes the public health community an apology. I also think that each organization and/or the Partners coalition itself is obligated to send a letter of clarification to our policy makers. I think the letter represents unethical public health conduct, and violates the basic code of public health ethics.
Why? Because the letter misrepresents the nature of the legislation in a profound way, and any professional medical or public health organization that read the letter should have been aware of this. Thus, signing on to the letter must be presumed to represent a willful (i.e., intentional) attempt to deceive policy makers about the true nature of the legislation.
The letter states that the legislation would provide FDA with authority over tobacco products that is "similar to the authority it has over other products." This is, frankly, a bunch of crap. In no way is the authority provided to FDA in this legislation similar to that provided to the Agency for the regulation of other products, such as food and drugs. In fact, it is fundamentally different.
If any of the organizations took the time to read the bill before signing on to the letter, they would have immediately had to notice the very first major provision of the legislation. Section 901(a), entitled "FDA Authority over Tobacco Products," reads: "Tobacco products shall be regulated by the Secretary under this chapter and shall not be subject to the provisions of chapter V." And what is chapter V? It is the entire regulatory authority for ensuring the safety of drugs and devices.
And the bill itself does not give FDA the major aspects of the authority it has over food and drugs.
Most importantly, it cannot remove a tobacco product from the market under any circumstances, even if it is deadly. In contrast, a drug or device can and must be immediately removed from the market if it is found to cause serious health consequences: "If the Secretary finds that there is a reasonable probability that a device intended for human use would cause serious, adverse health consequences or death, the Secretary shall issue an order requiring the appropriate person (including the manufacturers, importers, distributors, or retailers of the device) - (A) to immediately cease distribution of such device." [see 21 U.S.C. chapter IX, section 360(h)(e)(1)]
Unlike its authority over food additives, the Agency is not required to do anything about tobacco additives, even if such additives are known to be deadly. In contrast, food additives are not allowable unless "the proposed use of the food additive ... will be safe: Provided, That no additive shall be deemed to be safe if it is found to induce cancer when ingested by man or animal." [see 21 U.S.C. chapter IX, section 348(c)(3)(A)]
Unlike its authority over drugs, the Agency is not required to deem a tobacco product as being misbranded, and not allowable, if it is deadly if used as intended. In contrast, a drug is automatically deemed to be misbranded "if it is dangerous to health when used in the dosage or manner, or with the frequency or duration prescribed, recommended, or suggested in the labeling thereof." [see 21 U.S.C. chapter IX, section 352(j)]
Moreover, unlike its authority over drugs, the Agency is not allowed to establish a system by which adverse events related to the use of tobacco products are required to be reported. In contrast, chapter V sets up a system for "receiving reports of adverse events regarding drugs." [see 21 U.S.C. chapter IX, section 355b(a)]
As I think should be obvious, it is very clear that the FDA legislation does not give the Agency authority over tobacco products "similar to the authority it has over other products." In fact, the authority is about as different as one could imagine.
It is also clear that the legislation does not "subject tobacco products to the same consumer protections...applied to other products." This statement, in fact, comes dangerously close to being not just misleading, but grossly inaccurate.
And the statement that "Just as we entrust FDA with the authority to approve every ingredient in food to ensure safety, we should give FDA the same authority to regulate tobacco products" implies that the FDA legislation would give FDA authority to "approve every ingredient" in cigarettes, which is completely false.
In signing this letter, the organizations that make up the "Partners for Effective Tobacco Policy" have, I think, violated accepted standards of professional public health conduct that require public health organizations to provide the public with full and accurate information that is necessary to make decisions on policies. This is what the APHA Public Health Code of Ethics calls the "community-level" equivalent of the individual-level ethical principle of informed consent:
"Public health institutions should provide communities with the information they have that is needed for decisions on policies or programs and should obtain the community’s consent for their implementation. ... there is a moral obligation in some instances to share what is known. For example, active and informed participation in policy-making processes requires access to relevant information. ...Such processes depend upon an informed community. The information obtained by public health institutions is to be considered public property and made available to the public."
The letter has not only failed to inform members of Congress of the critical differences in the regulatory system that H.R. 1376/S. 666 sets up for tobacco products compared to FDA's authority over food and drugs, but even worse, it has completely misled them about these differences.
Note that I am not arguing here that the FDA legislation should necessarily give the Agency authority that is similar to its authority over food and drugs. Such a regulatory framework would most likely require tobacco products to be removed from the market. But the Partners' misrepresentation of the nature of FDA authority over tobacco products as provided by this legislation is inappropriate, irresponsible, and unethical.
I would certainly hope and expect to see a retraction and apology for this letter, either by the entire coalition as a whole, or by each of the 34 organizations that should feel ashamed for having taken part in such a deceptive and inappropriate lobbying endeavor.
Thursday, May 19, 2005
Inaugural Tobacco Control Advocate of the Year Award
Twice each year (and more often if funding permits), I will recognize a tobacco control advocate for unique and outstanding contributions to the advancement of the goal of reducing tobacco-related morbidity and mortality in the United States. Today, I am announcing the recipient of the first Tobacco Control Advocate of the Year Award...
...Bill Godshall, Executive Director of Smokefree Pennsylvania.
The Rest of the Story
I cannot think of anyone in the tobacco control movement who has done more for the public's health and for the movement itself, with extremely limited funding, than Bill Godshall.
Bill founded SmokeFree Pennsylvania in 1990, and for the past 15 years has served as its executive director. SmokeFree Pennsylvania, under Bill's leadership and on a shoe-string budget, has successfully advocated for clean indoor air policies, tobacco marketing restrictions to youth, and nicotine addiction treatment services. Although originally formed as a statewide grassroots organization, Bill has expanded SmokeFree Pennsylvania and has become so prominent and important a member of the tobacco control movement that the organization is a major part of most discussions over national tobacco control policy initiatives.
Bill also maintains an email network (the Bill Godshall Announcement List) which provides timely information and critical analysis of the most important national and local tobacco control policy issues to more than 17,000 public health advocates throughout the country. There have been nearly 1,500 messages posted by Bill to this network of local advocates.
Although Bill's contributions to the movement are too numerous to mention, several highlights stand out to me.
Bill played an instrumental role in the successful effort to derail the proposed Congressional $368.5 billion tobacco bailout in 1997, which would have given the tobacco industry immunity from any meaningful legal liability. Had the settlement been enacted, the Engle case, which resulted in a jury verdict of $145 billion against the tobacco companies, would never have seen the light of day. In fact, the many recent victories of plaintiffs against the tobacco companies would never have occurred, and the landscape of how the public views the tobacco industry today would be markedly different.
Bill played an instrumental role in the development of the Save Lives, Not Tobacco coalition, in which 156 public health organizations joined together to oppose the global bailout. Bill served as the coalition's communications director, and was highly successful in obtaining national media attention that highlighted the fact that the tobacco settlement would have shielded the industry from class action lawsuits and punitive damages, obstructing the pursuit of justice by affected smokers for all time to come. Bill was featured in a number of sentinel articles, including a critical August 1, 1997 article in the Wall Street Journal: Grass-roots activists try to derail tobacco settlement (page A16).
In the book Smoke in their Eyes: Lessons in Movement Leadership from the Tobacco Wars, Bill was described as a "scourge" who was "energetic" and "relentless," and for whom "descrediting and blowing apart ENACT was a labor of love and he dedicated himself to that task." Bill is described as one of the three harshest critics of the global bailout, along with the American Lung Association's John Garrison and Public Citizen's Alan Morrison.
A second highlight is Bill's tremendous contributions and leading role in what was ultimately an unsuccessful effort to convince the Attorneys General to oppose the Master Settlement Agreement deal. In retrospect, Bill must be viewed as having had tremendous vision for his accurate analysis of the likely effects of the deal.
A third highlight is Bill's central role in the successful effort to derail the proposed FDA tobacco legislation during the 2004 Congressional session, and his continuing efforts to kill this Philip Morris sweetheart deal during the current session.
A fourth highlight is Bill's role in helping to expose the tobacco industry's sponsorship of legislation to criminalize or penalize young people for smoking. He was featured in a 1999 CBS 60 Minutes episode that publicly exposed this issue.
Most recently, Bill miraculously was the only individual to recognize that the state of Pennsylvania had inadvertently repealed its preemption of clean indoor air legislation. His current efforts to bring this to light will most certainly result in major public health advances in his home state.
What I admire most about Bill is the fact that he tells it like it is. He does not back down from the truth and from what he believes is right. He is not afraid to go up against anyone, whether it is the tobacco industry or even our own public health organizations at times when he feels they are acting inappropriately. And all of his efforts and accomplishments have been realized with little more than his own initiative and determination, and his own self-funding. While most of us require a budget and substantial funding to accomplish what we do, Bill does even more, and he has done it with little funding.
Perhaps the best quote to demonstrate Bill's approach is from a May 23, 2000 Pittsburgh Post-Gazette article, in which Bill was debating University of Pittsburgh Cancer Institute director Ronald Herberman over the importance of allocating a substantial portion of tobacco settlement funds for smoking prevention and cessation programs. Herberman wanted the majority of tobacco control funds to go to research, stating that more research was needed on why people smoke and that most tobacco control programs were a waste: "We don't believe that the state of the art, the current billboards or media campaigns and so forth, are nearly close enough to address some of the problems." Bill's response was: "The state of the art is in California, Florida, and Massachusetts. The problem is we need to get some of the state of the art in Pennsylvania -- we don't have the state of the art because Herberman is lobbying against it."
For his dedication and his accomplishments, and in recognition of his receipt of the Rest of the Story's Tobacco Control Advocate of the Year award, Bill will be awarded a prize of $368.50, one dollar for each of the billion dollars that would have enabled a bailout of the tobacco industry had Bill not been active in the tobacco control movement.
...Bill Godshall, Executive Director of Smokefree Pennsylvania.
The Rest of the Story
I cannot think of anyone in the tobacco control movement who has done more for the public's health and for the movement itself, with extremely limited funding, than Bill Godshall.
Bill founded SmokeFree Pennsylvania in 1990, and for the past 15 years has served as its executive director. SmokeFree Pennsylvania, under Bill's leadership and on a shoe-string budget, has successfully advocated for clean indoor air policies, tobacco marketing restrictions to youth, and nicotine addiction treatment services. Although originally formed as a statewide grassroots organization, Bill has expanded SmokeFree Pennsylvania and has become so prominent and important a member of the tobacco control movement that the organization is a major part of most discussions over national tobacco control policy initiatives.
Bill also maintains an email network (the Bill Godshall Announcement List) which provides timely information and critical analysis of the most important national and local tobacco control policy issues to more than 17,000 public health advocates throughout the country. There have been nearly 1,500 messages posted by Bill to this network of local advocates.
Although Bill's contributions to the movement are too numerous to mention, several highlights stand out to me.
Bill played an instrumental role in the successful effort to derail the proposed Congressional $368.5 billion tobacco bailout in 1997, which would have given the tobacco industry immunity from any meaningful legal liability. Had the settlement been enacted, the Engle case, which resulted in a jury verdict of $145 billion against the tobacco companies, would never have seen the light of day. In fact, the many recent victories of plaintiffs against the tobacco companies would never have occurred, and the landscape of how the public views the tobacco industry today would be markedly different.
Bill played an instrumental role in the development of the Save Lives, Not Tobacco coalition, in which 156 public health organizations joined together to oppose the global bailout. Bill served as the coalition's communications director, and was highly successful in obtaining national media attention that highlighted the fact that the tobacco settlement would have shielded the industry from class action lawsuits and punitive damages, obstructing the pursuit of justice by affected smokers for all time to come. Bill was featured in a number of sentinel articles, including a critical August 1, 1997 article in the Wall Street Journal: Grass-roots activists try to derail tobacco settlement (page A16).
In the book Smoke in their Eyes: Lessons in Movement Leadership from the Tobacco Wars, Bill was described as a "scourge" who was "energetic" and "relentless," and for whom "descrediting and blowing apart ENACT was a labor of love and he dedicated himself to that task." Bill is described as one of the three harshest critics of the global bailout, along with the American Lung Association's John Garrison and Public Citizen's Alan Morrison.
A second highlight is Bill's tremendous contributions and leading role in what was ultimately an unsuccessful effort to convince the Attorneys General to oppose the Master Settlement Agreement deal. In retrospect, Bill must be viewed as having had tremendous vision for his accurate analysis of the likely effects of the deal.
A third highlight is Bill's central role in the successful effort to derail the proposed FDA tobacco legislation during the 2004 Congressional session, and his continuing efforts to kill this Philip Morris sweetheart deal during the current session.
A fourth highlight is Bill's role in helping to expose the tobacco industry's sponsorship of legislation to criminalize or penalize young people for smoking. He was featured in a 1999 CBS 60 Minutes episode that publicly exposed this issue.
Most recently, Bill miraculously was the only individual to recognize that the state of Pennsylvania had inadvertently repealed its preemption of clean indoor air legislation. His current efforts to bring this to light will most certainly result in major public health advances in his home state.
What I admire most about Bill is the fact that he tells it like it is. He does not back down from the truth and from what he believes is right. He is not afraid to go up against anyone, whether it is the tobacco industry or even our own public health organizations at times when he feels they are acting inappropriately. And all of his efforts and accomplishments have been realized with little more than his own initiative and determination, and his own self-funding. While most of us require a budget and substantial funding to accomplish what we do, Bill does even more, and he has done it with little funding.
Perhaps the best quote to demonstrate Bill's approach is from a May 23, 2000 Pittsburgh Post-Gazette article, in which Bill was debating University of Pittsburgh Cancer Institute director Ronald Herberman over the importance of allocating a substantial portion of tobacco settlement funds for smoking prevention and cessation programs. Herberman wanted the majority of tobacco control funds to go to research, stating that more research was needed on why people smoke and that most tobacco control programs were a waste: "We don't believe that the state of the art, the current billboards or media campaigns and so forth, are nearly close enough to address some of the problems." Bill's response was: "The state of the art is in California, Florida, and Massachusetts. The problem is we need to get some of the state of the art in Pennsylvania -- we don't have the state of the art because Herberman is lobbying against it."
For his dedication and his accomplishments, and in recognition of his receipt of the Rest of the Story's Tobacco Control Advocate of the Year award, Bill will be awarded a prize of $368.50, one dollar for each of the billion dollars that would have enabled a bailout of the tobacco industry had Bill not been active in the tobacco control movement.
Wednesday, May 18, 2005
Citizens' Commission Amicus Brief: Further Commentary
While I have already commented on the Citizens' Commission to Protect the Truth's failure to be forthright in disclosing its conflict of interest (specifically, being affiliated with and funded by the American Legacy Foundation) in its filing of its recent amicus brief in the legal dispute between Lorillard and the American Legacy Foundation over whether the "truth" campaign violated the anti-vilification clause of the Master Settlement Agreement, I think the merits of the actual legal argument in the brief are also worthy of comment.
The background to the brief is as follows: Lorillard (maker of Newport, among other cigarette brands), has threatened to sue the American Legacy Foundation for violating the terms of the Master Settlement Agreement through its "truth" anti-smoking campaign. Specifically, Lorillard contends that the "truth" campaign ads violate the anti-vilification clause of the settlement agreement (section VI[h]), which states that: "The National Public Education Fund shall be used only for public education and advertising regarding the addictiveness, health effects, and social costs related to the use of tobacco products and shall not be used for any personal attack on, or vilification of, any person (whether by name or business affiliation), company, or governmental agency, whether individually or collectively."
The American Legacy Foundation has apparently filed a motion in the Court of Chancery of the State of Delaware to attempt to restrain Lorillard from filing suit on the above basis. The basic argument advanced by the Commission in the amicus brief, which supports the Foundation's motion, is that: "If Lorillard, and tobacco companies generally, are permitted to threaten and bring suit against the American Legacy Foundation every time it feels that a truth(R) campaign advertisement will impact its sales, the adverse effect on the public health will be vast. ... Rather than placing its resources and energy into generating powerful, effective anti-smoking advertisements, the American Legacy Foundation would be forced to appease the tobacco companies under the threat of litigation."
Importantly, the brief also states that: "Merely entertaining this suit, and others of its type, will impact Legacy's truth(R) campaign. Putting aside the possibility of a declaration that the truth(R) campaign violates the anti-vilification provision of the MSA, the mere threat of such lawsuits will carry, practically speaking, the same effect." And it concludes by stating: "The only way for this Court to preserve the effectiveness of Legacy's truth(R) campaign, and thereby allow the nation's most successful smoking prevention campaign to continue its efforts, is to declare and decree that Lorillard cannot bring suit against Legacy pursuant to the MSA."
The Rest of the Story
As much as I deplore Lorillard and dislike its attempt to invoke the anti-vilification clause of the MSA, the key legal issue in question is not whether Lorillard is a terrible company or not or whether allowing it to sue Legacy will ultimately harm the public's health, but whether it is reasonable and legally sound under the Master Settlement Agreement and the laws of the United States to allow such a lawsuit.
While the Commission is at least somewhat accurate in defending the importance of the "truth" campaign (see more on this below) and in noting that allowing Lorillard and other companies to sue Legacy based on the anti-vilification clause might weaken or even devastate the campaign, that is unfortunately not the central legal question here. The main question is whether a lawsuit is allowable and reasonable under the law, which includes the contract under which the two parties are acting.
In order to convince a judge not to allow this lawsuit, I think that the Commission would have to show that either: (1) there is no legal basis for Lorillard to sue Legacy on the alleged anti-vilification clause violation under the MSA; or (2) that although a lawsuit is allowable, this suit is so frivolous or unreasonable that allowing it would undermine the operation of the Foundation for little meaningful reason.
The amicus brief does not attempt to make any argument to support the first point, although it certainly asks the judge to make such a declaration in requesting a decree that "Lorillard cannot bring suit against Legacy pursuant to the MSA." The brief does argue that allowing a lawsuit would undermine the operation of the Foundation, but it provides no analysis or evidence to support the contention that such a lawsuit would be frivolous or unreasonable in any way, other than to simply state that it would cause problems for Legacy. But that alone does not seem enough to restrain Lorillard from filing suit under the MSA if its legal contention is at least reasonable (note that it does not have to be correct, just reasonable).
It seems clear that Lorillard does have a basis to assert claims against Legacy pursuant to the MSA (the Attorneys General have certainly been given the ability to assert claims against the tobacco companies under the MSA; it seems that the contract would work both ways). So the question is whether Lorillard's invokation of the anti-vilification clause is unreasonable. Is, as the Commission claims, Lorillard simply trying "to intimidate Legacy under the guise of anti-vilification provisions."
Here, a careful reading of the anti-vilification provision is critical. The clause states that the Foundation's ads must not make "any personal attack on, or vilification of, any person (whether by name or business affiliation), company, or governmental agency, whether individually or collectively." To vilify is defined as either "to lower in estimation or importance" or "to utter slanderous and abusive statements against."
While I personally would not interpret the anti-vilification clause in such a way that it would lead to a conclusion that some of the "truth" campaign ads have violated the provision, I do have to admit that it does not seem unreasonable to argue that some of the ads do attempt to lower the public's estimation of the tobacco companies. So I think the significant legal question for a court to determine is whether the definition of "vilify" would fall under the first (more general) or second (more specific) definition above. Under the first definition, it may not be unreasonable to interpret the MSA in such a way that the "truth" campaign ads represent a violation of the clause. Under the second definition, the "truth" campaign is home-free.
The problem is that it is not up to me to decide how to interpret the MSA. The relevant question is really whether there is a legitimate potential legal argument that the ads could violate the MSA, such that a court's hearing of the issue becomes essential for the tobacco company's interest in pursuing legal enforcement of the binding contract that both parties are subject to. And I think because there is at least the possibility of a more general interpretation of the anti-vilification clause, a lawsuit on this basis is not frivolous, but is within the realm of reason.
I therefore am not persuaded by the Commission's legal brief. If anything, I think that it is in the best interests of the public's health in the long run to defend the legal system and the opportunity for parties to pursue justice under the laws of our nation. To cut off or restrain the legal ability of the tobacco companies to seek justice under a contract that is legally binding, just because the companies are very bad and we are very good, does not advance the overall interests of public health in the long run. And, frankly, I think it may violate legitimate legal rights of the tobacco companies. Yes, I do think that all entities in our society do have certain legal rights that cannot be stripped away simply on the basis of their being faulty in intention or action.
What is really needed in this case is not a blanket request to the judge to interfere with Lorillard's apparent legal rights, but rather a compelling argument why the judge should rule that Legacy has not violated the anti-vilification clause. It seems to me that it is going to basically come down to which of the two basic definitions the judge adopts and evidence that it is indeed the second definition that is more appropriate in this situation, based on the context in which the MSA was negotiated and signed, would be truly valuable in helping Legacy to preserve the integrity of the "truth" campaign.
One additional statement in the brief deserves comment. The Commission wrote that: "It is beyond dispute that the truth(R) campaign's advertising is cutting-edge, and has caused a significant decrease in youth smoking." While there is no doubt that the "truth" campaign is cutting-edge, I certainly do not think that it is beyond dispute that the campaign has significantly decreased youth smoking. Dr. Joel Moskowitz has published an important comment noting that the paper cited in the amicus brief to support the above statement had several limitations that may interfere with the ability to conclude that the campaign had a significant effect. And I have myself argued that the evidence presented in the AJPH paper does not support the conclusion that the "truth" campaign led to a significant reduction in youth smoking. Whether Moskowitz and I are correct or not, it does not seem accurate under the circumstances to claim that the campaign effects on youth smoking are "beyond dispute." They are in fact being disputed, and by reputable sources (well, at least one).
Finally, let me be clear that I am not criticizing the Citizens' Commission for advancing its argument. It has a legitimate interest in doing so, and there's nothing wrong in it pursuing this approach. It's at least slightly possible that the approach may work. My argument here is not that the amicus brief is inappropriate (other than the failure to be forthright about the Commission's affiliation with Legacy). My argument is that the brief is not particularly relevant or valid.
The real blame here lies with the Attorneys General who signed such a shoddy agreement in the first place as well as with the public health organizations that failed to unequivocally oppose the signing of the settlement. Unfortunately, if you sign a really bad contract you have to live with your mistakes. The Attorneys General, in signing an agreement with the anti-vilification clause present, presumably knew full well what they were getting themselves into. It shouldn't come as any surprise that the tobacco companies wanted that clause in there so that they could attempt to prevent exactly the kind of hard-hitting ads that Legacy is producing.
That "rather than placing its resources and energy into generating powerful, effective anti-smoking advertisements," the American Legacy Foundation is now "forced to appease the tobacco companies under the threat of litigation" is not a violation of legal principles in this country. Instead, it is simply the result of a really bad contract that should never have been signed in the first place. Unfortunately, it is the anti-vilification provision itself that is the problem here, not simply the fact that the tobacco companies have bad intentions.
The companies were successful in extracting such an advantageous provision in the contract. They certainly have the right to now take advantage of that provision, and I don't blame them for doing so. Legacy and the Commission can complain all they want about how evil Lorillard may be, but it is the Attorneys General who signed the contract knowing full well about the anti-vilification clause who are to blame for this mess.
The background to the brief is as follows: Lorillard (maker of Newport, among other cigarette brands), has threatened to sue the American Legacy Foundation for violating the terms of the Master Settlement Agreement through its "truth" anti-smoking campaign. Specifically, Lorillard contends that the "truth" campaign ads violate the anti-vilification clause of the settlement agreement (section VI[h]), which states that: "The National Public Education Fund shall be used only for public education and advertising regarding the addictiveness, health effects, and social costs related to the use of tobacco products and shall not be used for any personal attack on, or vilification of, any person (whether by name or business affiliation), company, or governmental agency, whether individually or collectively."
The American Legacy Foundation has apparently filed a motion in the Court of Chancery of the State of Delaware to attempt to restrain Lorillard from filing suit on the above basis. The basic argument advanced by the Commission in the amicus brief, which supports the Foundation's motion, is that: "If Lorillard, and tobacco companies generally, are permitted to threaten and bring suit against the American Legacy Foundation every time it feels that a truth(R) campaign advertisement will impact its sales, the adverse effect on the public health will be vast. ... Rather than placing its resources and energy into generating powerful, effective anti-smoking advertisements, the American Legacy Foundation would be forced to appease the tobacco companies under the threat of litigation."
Importantly, the brief also states that: "Merely entertaining this suit, and others of its type, will impact Legacy's truth(R) campaign. Putting aside the possibility of a declaration that the truth(R) campaign violates the anti-vilification provision of the MSA, the mere threat of such lawsuits will carry, practically speaking, the same effect." And it concludes by stating: "The only way for this Court to preserve the effectiveness of Legacy's truth(R) campaign, and thereby allow the nation's most successful smoking prevention campaign to continue its efforts, is to declare and decree that Lorillard cannot bring suit against Legacy pursuant to the MSA."
The Rest of the Story
As much as I deplore Lorillard and dislike its attempt to invoke the anti-vilification clause of the MSA, the key legal issue in question is not whether Lorillard is a terrible company or not or whether allowing it to sue Legacy will ultimately harm the public's health, but whether it is reasonable and legally sound under the Master Settlement Agreement and the laws of the United States to allow such a lawsuit.
While the Commission is at least somewhat accurate in defending the importance of the "truth" campaign (see more on this below) and in noting that allowing Lorillard and other companies to sue Legacy based on the anti-vilification clause might weaken or even devastate the campaign, that is unfortunately not the central legal question here. The main question is whether a lawsuit is allowable and reasonable under the law, which includes the contract under which the two parties are acting.
In order to convince a judge not to allow this lawsuit, I think that the Commission would have to show that either: (1) there is no legal basis for Lorillard to sue Legacy on the alleged anti-vilification clause violation under the MSA; or (2) that although a lawsuit is allowable, this suit is so frivolous or unreasonable that allowing it would undermine the operation of the Foundation for little meaningful reason.
The amicus brief does not attempt to make any argument to support the first point, although it certainly asks the judge to make such a declaration in requesting a decree that "Lorillard cannot bring suit against Legacy pursuant to the MSA." The brief does argue that allowing a lawsuit would undermine the operation of the Foundation, but it provides no analysis or evidence to support the contention that such a lawsuit would be frivolous or unreasonable in any way, other than to simply state that it would cause problems for Legacy. But that alone does not seem enough to restrain Lorillard from filing suit under the MSA if its legal contention is at least reasonable (note that it does not have to be correct, just reasonable).
It seems clear that Lorillard does have a basis to assert claims against Legacy pursuant to the MSA (the Attorneys General have certainly been given the ability to assert claims against the tobacco companies under the MSA; it seems that the contract would work both ways). So the question is whether Lorillard's invokation of the anti-vilification clause is unreasonable. Is, as the Commission claims, Lorillard simply trying "to intimidate Legacy under the guise of anti-vilification provisions."
Here, a careful reading of the anti-vilification provision is critical. The clause states that the Foundation's ads must not make "any personal attack on, or vilification of, any person (whether by name or business affiliation), company, or governmental agency, whether individually or collectively." To vilify is defined as either "to lower in estimation or importance" or "to utter slanderous and abusive statements against."
While I personally would not interpret the anti-vilification clause in such a way that it would lead to a conclusion that some of the "truth" campaign ads have violated the provision, I do have to admit that it does not seem unreasonable to argue that some of the ads do attempt to lower the public's estimation of the tobacco companies. So I think the significant legal question for a court to determine is whether the definition of "vilify" would fall under the first (more general) or second (more specific) definition above. Under the first definition, it may not be unreasonable to interpret the MSA in such a way that the "truth" campaign ads represent a violation of the clause. Under the second definition, the "truth" campaign is home-free.
The problem is that it is not up to me to decide how to interpret the MSA. The relevant question is really whether there is a legitimate potential legal argument that the ads could violate the MSA, such that a court's hearing of the issue becomes essential for the tobacco company's interest in pursuing legal enforcement of the binding contract that both parties are subject to. And I think because there is at least the possibility of a more general interpretation of the anti-vilification clause, a lawsuit on this basis is not frivolous, but is within the realm of reason.
I therefore am not persuaded by the Commission's legal brief. If anything, I think that it is in the best interests of the public's health in the long run to defend the legal system and the opportunity for parties to pursue justice under the laws of our nation. To cut off or restrain the legal ability of the tobacco companies to seek justice under a contract that is legally binding, just because the companies are very bad and we are very good, does not advance the overall interests of public health in the long run. And, frankly, I think it may violate legitimate legal rights of the tobacco companies. Yes, I do think that all entities in our society do have certain legal rights that cannot be stripped away simply on the basis of their being faulty in intention or action.
What is really needed in this case is not a blanket request to the judge to interfere with Lorillard's apparent legal rights, but rather a compelling argument why the judge should rule that Legacy has not violated the anti-vilification clause. It seems to me that it is going to basically come down to which of the two basic definitions the judge adopts and evidence that it is indeed the second definition that is more appropriate in this situation, based on the context in which the MSA was negotiated and signed, would be truly valuable in helping Legacy to preserve the integrity of the "truth" campaign.
One additional statement in the brief deserves comment. The Commission wrote that: "It is beyond dispute that the truth(R) campaign's advertising is cutting-edge, and has caused a significant decrease in youth smoking." While there is no doubt that the "truth" campaign is cutting-edge, I certainly do not think that it is beyond dispute that the campaign has significantly decreased youth smoking. Dr. Joel Moskowitz has published an important comment noting that the paper cited in the amicus brief to support the above statement had several limitations that may interfere with the ability to conclude that the campaign had a significant effect. And I have myself argued that the evidence presented in the AJPH paper does not support the conclusion that the "truth" campaign led to a significant reduction in youth smoking. Whether Moskowitz and I are correct or not, it does not seem accurate under the circumstances to claim that the campaign effects on youth smoking are "beyond dispute." They are in fact being disputed, and by reputable sources (well, at least one).
Finally, let me be clear that I am not criticizing the Citizens' Commission for advancing its argument. It has a legitimate interest in doing so, and there's nothing wrong in it pursuing this approach. It's at least slightly possible that the approach may work. My argument here is not that the amicus brief is inappropriate (other than the failure to be forthright about the Commission's affiliation with Legacy). My argument is that the brief is not particularly relevant or valid.
The real blame here lies with the Attorneys General who signed such a shoddy agreement in the first place as well as with the public health organizations that failed to unequivocally oppose the signing of the settlement. Unfortunately, if you sign a really bad contract you have to live with your mistakes. The Attorneys General, in signing an agreement with the anti-vilification clause present, presumably knew full well what they were getting themselves into. It shouldn't come as any surprise that the tobacco companies wanted that clause in there so that they could attempt to prevent exactly the kind of hard-hitting ads that Legacy is producing.
That "rather than placing its resources and energy into generating powerful, effective anti-smoking advertisements," the American Legacy Foundation is now "forced to appease the tobacco companies under the threat of litigation" is not a violation of legal principles in this country. Instead, it is simply the result of a really bad contract that should never have been signed in the first place. Unfortunately, it is the anti-vilification provision itself that is the problem here, not simply the fact that the tobacco companies have bad intentions.
The companies were successful in extracting such an advantageous provision in the contract. They certainly have the right to now take advantage of that provision, and I don't blame them for doing so. Legacy and the Commission can complain all they want about how evil Lorillard may be, but it is the Attorneys General who signed the contract knowing full well about the anti-vilification clause who are to blame for this mess.
Tuesday, May 17, 2005
Citizens' Commission Still Not Revealing the Truth; How Can It Be Expected to Protect the Truth?
In its latest amicus brief, this time filed in support of the American Legacy Foundation's position in a legal battle with Lorillard regarding whether the "truth" anti-smoking campaign violates the anti-vilification clause of the Master Settlement Agreement, the Citizens' Commission to Protect the Truth denies any affiliation with the Legacy Foundation.
In its previous amicus briefs, the Citizens' Commission failed completely to reveal its financial relationship with the American Legacy Foundation. According to the Commission's web site: "Principal funding for The Commission comes from the National Association of Attorneys General (NAAG) through a $1.5 million pass-through grant from the American Legacy Foundation."
Now, the Citizens' Commission is finally disclosing that its funding comes from NAAG through Legacy, but it is denying that it is affiliated with Legacy, basing this claim on the contention that the NAAG funds are being transmitted to the Commission through Legacy purely as an administrative function: "The Commission is not affiliated with Legacy. It is an independent organization developed to serve the public health in connection with tobacco use and prevention. Funding for the Commission was provided by the National Association of Attorneys General, and was transmitted to the Commission through Legacy purely as an administrative function."
The Citizens' Commission's claim that it is not affiliated with Legacy is supported in the amicus brief by reference to a March 18 letter from Attorney General William Sorrell (president of NAAG) to Dr. Joseph A. Califano, Jr., Chairman and President of the National Center on Addiction and Substance Abuse at Columbia University (CASA) and Chairman of the Citizens' Commission, stating: "This letter is to confirm that the funding for the Citizens Commission to Protect the Truth was initially provided by NAAG to the American Legacy Foundation with the belief that they would be used for support to the Commission."
The Rest of the Story
My initial impression upon seeing that the Citizens' Commission did indeed, for the first time in one of its amicus briefs, address the issue of its funding from the Legacy Foundation, was that the Commission was finally revealing the truth and disclosing its conflict of interest in arguing on behalf of the Foundation. However, to my surprise, the Commission does just the opposite: it reveals the funding but then goes on to claim that it is not affiliated with Legacy. Rather than revealing the truth, this amicus brief actually attempts to obscure and hide the truth.
The facts, based solely on admissions of the Citizens' Commission itself, are that:
The word "affiliated" is defined as "closely associated with another typically in a dependent or subordinate position." Since the Commission receives funding from Legacy, it follows that the two organizations are "closely associated." And the fact that the Commission's funding comes from Legacy does represent the typical "dependent" position to which the definition refers.
The exhibit (i.e., the letter from NAAG to the Commission) offered in the brief to support the contention that there is no affiliation between the Commission and Legacy demonstrates just the opposite. It makes it eminently clear that the two are strongly affiliated via funding from NAAG to Legacy that was specifically provided to "support the Commission."
The Commission's argument that there is no affiliation between itself and Legacy because the funding from NAAG was transmitted to the Commission through Legacy "purely as an administrative function" is ridiculous. One could just as easily argue that university faculty members who are supported by the Association of Schools of Public Health (ASPH) STEP UP program (which is funded by Legacy through a grant to ASPH) are not affiliated with ASPH because ASPH serves purely an administrative function in transmitting Legacy's funds to the grant recipients.
Moreover, there a number of other reasons why it is ludicrous to argue that the Citizens' Commission is not affiliated with Legacy:
What is most disturbing about the latest Citizens' Commission action is not just the attempt to obscure the truth. It is the hypocrisy of the Commission representing itself, on the one hand, as an organization dedicated to "protecting the truth," and then on the other hand, trying to mislead a judge about the truth of its affiliation and its apparent conflict of interest in an important legal case.
How can the Citizens' Commission protect the truth if it has so much trouble telling the truth?
In its previous amicus briefs, the Citizens' Commission failed completely to reveal its financial relationship with the American Legacy Foundation. According to the Commission's web site: "Principal funding for The Commission comes from the National Association of Attorneys General (NAAG) through a $1.5 million pass-through grant from the American Legacy Foundation."
Now, the Citizens' Commission is finally disclosing that its funding comes from NAAG through Legacy, but it is denying that it is affiliated with Legacy, basing this claim on the contention that the NAAG funds are being transmitted to the Commission through Legacy purely as an administrative function: "The Commission is not affiliated with Legacy. It is an independent organization developed to serve the public health in connection with tobacco use and prevention. Funding for the Commission was provided by the National Association of Attorneys General, and was transmitted to the Commission through Legacy purely as an administrative function."
The Citizens' Commission's claim that it is not affiliated with Legacy is supported in the amicus brief by reference to a March 18 letter from Attorney General William Sorrell (president of NAAG) to Dr. Joseph A. Califano, Jr., Chairman and President of the National Center on Addiction and Substance Abuse at Columbia University (CASA) and Chairman of the Citizens' Commission, stating: "This letter is to confirm that the funding for the Citizens Commission to Protect the Truth was initially provided by NAAG to the American Legacy Foundation with the belief that they would be used for support to the Commission."
The Rest of the Story
My initial impression upon seeing that the Citizens' Commission did indeed, for the first time in one of its amicus briefs, address the issue of its funding from the Legacy Foundation, was that the Commission was finally revealing the truth and disclosing its conflict of interest in arguing on behalf of the Foundation. However, to my surprise, the Commission does just the opposite: it reveals the funding but then goes on to claim that it is not affiliated with Legacy. Rather than revealing the truth, this amicus brief actually attempts to obscure and hide the truth.
The facts, based solely on admissions of the Citizens' Commission itself, are that:
- "principal funding for The Commission comes from the National Association of Attorneys General through a $1.5 million pass-through grant from the American Legacy Foundation;" and
- "funding for the Citizens Commission to Protect the Truth was initially provided by NAAG to the American Legacy Foundation with the belief that they would be used for support to the Commission."
The word "affiliated" is defined as "closely associated with another typically in a dependent or subordinate position." Since the Commission receives funding from Legacy, it follows that the two organizations are "closely associated." And the fact that the Commission's funding comes from Legacy does represent the typical "dependent" position to which the definition refers.
The exhibit (i.e., the letter from NAAG to the Commission) offered in the brief to support the contention that there is no affiliation between the Commission and Legacy demonstrates just the opposite. It makes it eminently clear that the two are strongly affiliated via funding from NAAG to Legacy that was specifically provided to "support the Commission."
The Commission's argument that there is no affiliation between itself and Legacy because the funding from NAAG was transmitted to the Commission through Legacy "purely as an administrative function" is ridiculous. One could just as easily argue that university faculty members who are supported by the Association of Schools of Public Health (ASPH) STEP UP program (which is funded by Legacy through a grant to ASPH) are not affiliated with ASPH because ASPH serves purely an administrative function in transmitting Legacy's funds to the grant recipients.
Moreover, there a number of other reasons why it is ludicrous to argue that the Citizens' Commission is not affiliated with Legacy:
- Attorney General William Sorrell, the President of NAAG, is also the Treasurer and a Board member of the American Legacy Foundation. So even if the NAAG funds went directly to the Citizens' Commission, there would still be an affiliation with Legacy by virtue of Sorrell's dual role as a chief executive of both NAAG and Legacy.
- According to the Master Settlement Agreement, NAAG provides for the very creation of the American Legacy Foundation and two of its representatives automatically sit on Legacy's Board of Directors. Once again, even if NAAG directly funded the Commission, there would still be an affiliation with Legacy by virtue of the fact that NAAG is inextricably tied to Legacy - it is the creator of Legacy.
- CASA, the organization of which Dr. Califano is Chairman and President and which essentially serves as the recipient of funds to run the Commission, is itself funded by the American Legacy Foundation, according to its 2004 Annual Report.
What is most disturbing about the latest Citizens' Commission action is not just the attempt to obscure the truth. It is the hypocrisy of the Commission representing itself, on the one hand, as an organization dedicated to "protecting the truth," and then on the other hand, trying to mislead a judge about the truth of its affiliation and its apparent conflict of interest in an important legal case.
How can the Citizens' Commission protect the truth if it has so much trouble telling the truth?
Monday, May 16, 2005
Newly Invoked Loophole in MSA Threatens to Cement Bond Between States and Major Tobacco Companies
According to an article in the current issue of Business Week, Philip Morris has invoked yet another loophole in the Master Settlement Agreement (MSA) in an attempt to substantially lower its payments to the states, threatening not only current state budgets but also state reserves that may need to be tapped to fulfill bond obligations in states that have securitized MSA payments (see: Foust D, Byrnes N. The high cost of nicotine withdrawal: cigarette makers want settlement rebates from states. That could hurt taxpayers. Business Week, May 23, 2005, p.40).
According to the article, if all major participating manufacturers invoke the loophole, states may have to pay back as much as $1 billion to the tobacco companies immediately, with further rebates or payment reductions in years to come. The article predicts that such an outcome would result in severe consequences for states that have issued bonds backed by future MSA payments; 12 states, plus Puerto Rico and the District of Columbia have issued $19 billion in such bonds. If future MSA payments drop, these states may need to tap into reserve funds in order to avoid defaulting on these bonds. Thus, the loophole creates an enormous economic incentive for the states not to do anything that will decrease tobacco company revenues.
The attorneys general are apparently planning to contest the request for these MSA rebates, claiming, according to the article, that tobacco companies must "prove the states were negligent in policing the settlement."
The Rest of the Story
The loophole in question is the Non-Participating Manufacturer (NPM) Adjustment, a complex provision described in section IX(d)(1) of the Agreement. Basically, the provision states that if the market share of the participating manufacturers in any given year falls to more than 2 percentage points below the baseline aggregate market share for 1997, then MSA payments for the following year are reduced by a percentage equal to the amount of the market share loss exceeding 2 percentage points (that is, the market share loss minus 2 percentage points) times a factor of 3.
However, there are two exceptions to this adjustment. First, it does not hold if total domestic cigarette consumption is greater than it was from the participating manufacturers in 1997. Since cigarette consumption is falling, this is unlikely to occur and so will not nullify the NPM adjustment. Second, the adjustment only holds if the market share loss in any given year is at least partially a result of disadvantages to the participating manufacturers due to their participation in the MSA. Such a determination is to be made by "a nationally recognized firm of economic consultants."
As an example to demonstrate the provision, assume that the market share for participating manufacturers was 99.6% in 1997 and dropped to 91.9% in 2004 (these are the data cited in the Business Week article). The market share loss that exceeds 2% is 99.6-91.9-2.0, or 5.7%. The adjustment factor is then 5.7% times 3, or 17.1%. This means that total industry payments to the states will be reduced by 17.1% in 2005, assuming that domestic cigarette consumption is not higher than it was in 1997 and that the nationally recognized firm of economic consultants determines that participation in the MSA was a significant factor in the loss of market share by the participating manufacturers for 2004. Based on the $6.2 billion paid to the states in 2004, this would represent a loss of about $1.1 billion in state revenue.
Although the attorneys general are apparently going to fight the cigarette companies' request for this rebate, I don't see that they have much of an argument. Although complex, the non-participating manufacturer adjustment is quite clear. The only defense that the attorneys general appear to have is if they can correctly claim that the MSA was not a significant factor in the loss of market share for the participating manufacturers. However, given the magnitude of the payments being required under the MSA, it is difficult to imagine that a panel of economic consultants would not find that participation in the MSA was indeed a significant factor why non-participating manufacturers were able to make market share gains.
The argument, mentioned in the article and attributed to the attorneys general, that companies need to prove that the states were negligent in policing the settlement in order to make the NPM adjustment does not seem to be valid. It appears to me that the only issue up for consideration is whether or not being a party to the MSA was a significant factor in the loss of market share. My sense is that if this goes to an economic panel or to the courts, the tobacco companies will be successful in their attempt to collect the NPM rebates that are due to them.
All of this supports my earlier contention that the MSA represents the greatest public health blunder of my lifetime. Now, more than ever, the financial well-being of the states is inextricably tied to the economic health of the major tobacco companies, creating an overwhelmingly compelling incentive for the states not to enact any policies or take any actions that may endanger the sales and/or profits of the major tobacco companies. The states are now economic partners with the tobacco companies and as such, deserve a share of the blame for the most important epidemic of the 21st century.
According to the article, if all major participating manufacturers invoke the loophole, states may have to pay back as much as $1 billion to the tobacco companies immediately, with further rebates or payment reductions in years to come. The article predicts that such an outcome would result in severe consequences for states that have issued bonds backed by future MSA payments; 12 states, plus Puerto Rico and the District of Columbia have issued $19 billion in such bonds. If future MSA payments drop, these states may need to tap into reserve funds in order to avoid defaulting on these bonds. Thus, the loophole creates an enormous economic incentive for the states not to do anything that will decrease tobacco company revenues.
The attorneys general are apparently planning to contest the request for these MSA rebates, claiming, according to the article, that tobacco companies must "prove the states were negligent in policing the settlement."
The Rest of the Story
The loophole in question is the Non-Participating Manufacturer (NPM) Adjustment, a complex provision described in section IX(d)(1) of the Agreement. Basically, the provision states that if the market share of the participating manufacturers in any given year falls to more than 2 percentage points below the baseline aggregate market share for 1997, then MSA payments for the following year are reduced by a percentage equal to the amount of the market share loss exceeding 2 percentage points (that is, the market share loss minus 2 percentage points) times a factor of 3.
However, there are two exceptions to this adjustment. First, it does not hold if total domestic cigarette consumption is greater than it was from the participating manufacturers in 1997. Since cigarette consumption is falling, this is unlikely to occur and so will not nullify the NPM adjustment. Second, the adjustment only holds if the market share loss in any given year is at least partially a result of disadvantages to the participating manufacturers due to their participation in the MSA. Such a determination is to be made by "a nationally recognized firm of economic consultants."
As an example to demonstrate the provision, assume that the market share for participating manufacturers was 99.6% in 1997 and dropped to 91.9% in 2004 (these are the data cited in the Business Week article). The market share loss that exceeds 2% is 99.6-91.9-2.0, or 5.7%. The adjustment factor is then 5.7% times 3, or 17.1%. This means that total industry payments to the states will be reduced by 17.1% in 2005, assuming that domestic cigarette consumption is not higher than it was in 1997 and that the nationally recognized firm of economic consultants determines that participation in the MSA was a significant factor in the loss of market share by the participating manufacturers for 2004. Based on the $6.2 billion paid to the states in 2004, this would represent a loss of about $1.1 billion in state revenue.
Although the attorneys general are apparently going to fight the cigarette companies' request for this rebate, I don't see that they have much of an argument. Although complex, the non-participating manufacturer adjustment is quite clear. The only defense that the attorneys general appear to have is if they can correctly claim that the MSA was not a significant factor in the loss of market share for the participating manufacturers. However, given the magnitude of the payments being required under the MSA, it is difficult to imagine that a panel of economic consultants would not find that participation in the MSA was indeed a significant factor why non-participating manufacturers were able to make market share gains.
The argument, mentioned in the article and attributed to the attorneys general, that companies need to prove that the states were negligent in policing the settlement in order to make the NPM adjustment does not seem to be valid. It appears to me that the only issue up for consideration is whether or not being a party to the MSA was a significant factor in the loss of market share. My sense is that if this goes to an economic panel or to the courts, the tobacco companies will be successful in their attempt to collect the NPM rebates that are due to them.
All of this supports my earlier contention that the MSA represents the greatest public health blunder of my lifetime. Now, more than ever, the financial well-being of the states is inextricably tied to the economic health of the major tobacco companies, creating an overwhelmingly compelling incentive for the states not to enact any policies or take any actions that may endanger the sales and/or profits of the major tobacco companies. The states are now economic partners with the tobacco companies and as such, deserve a share of the blame for the most important epidemic of the 21st century.
Statement by R.J. Reynolds Supports Assertion that FDA Legislation Would Destroy Harm Reduction Efforts
In a May 4 commentary in USA Today, R.J. Reynolds executive vice president for external relations Tommy J. Payne opined that the proposed FDA legislation would destroy any motivation on the part of tobacco companies to develop reduced risk products. Payne suggested that the main effect of the legislation would be to freeze existing market shares, which would of course benefit Philip Morris, the existing market leader.
According to Payne: "USA Today's readers need to know that FDA control of the tobacco industry would extend well beyond efforts to reduce risk and would, in fact, seriously impede future progress along those lines. Passage of FDA-tobacco legislation like that proposed last year would virtually destroy competition in the tobacco industry, including motivation to develop reduced-risk products. It would grant unlimited power to the industry market leader, locking in existing market share trends and the status quo."
The Rest of the Story
Although one must always exercise caution when interpreting public statements from tobacco company spokespersons, this statement from R.J. Reynolds does appear to support the assertion, expressed previously in The Rest of the Story, that passage of the FDA legislation would stifle competition to produce truly reduced risk cigarette products and take away any real incentive for tobacco companies to develop and market products that might actually result in substantial reductions in health risks.
It also supports the assertion, expressed earlier, that the FDA legislation really represents what would better be called the "Marlboro Monopoly Act." This is, above all, not a bill to protect the public's health, but a bill to protect and preserve the financial interests of the nation's leading tobacco company.
According to Payne: "USA Today's readers need to know that FDA control of the tobacco industry would extend well beyond efforts to reduce risk and would, in fact, seriously impede future progress along those lines. Passage of FDA-tobacco legislation like that proposed last year would virtually destroy competition in the tobacco industry, including motivation to develop reduced-risk products. It would grant unlimited power to the industry market leader, locking in existing market share trends and the status quo."
The Rest of the Story
Although one must always exercise caution when interpreting public statements from tobacco company spokespersons, this statement from R.J. Reynolds does appear to support the assertion, expressed previously in The Rest of the Story, that passage of the FDA legislation would stifle competition to produce truly reduced risk cigarette products and take away any real incentive for tobacco companies to develop and market products that might actually result in substantial reductions in health risks.
It also supports the assertion, expressed earlier, that the FDA legislation really represents what would better be called the "Marlboro Monopoly Act." This is, above all, not a bill to protect the public's health, but a bill to protect and preserve the financial interests of the nation's leading tobacco company.
Major Loophole in Georgia Restaurant Smoking Law Could Nullify Health Protections
The Georgia "Smokefree" Air Act of 2005 could result in extremely hazardous working conditions for many restaurant workers in the state, thanks to a major loophole that essentially nullifies any guaranteed health protections in the bill. In addition, this loophole is sure to cause confusion and delay, and to create an expensive alteration of the restaurant environment that will lead to an unlevel playing field for restaurant owners and employees alike.
The loophole is exception 9B, which exempts from the smoking law any "private rooms in restaurants and bars if such rooms are enclosed and have an air handling system independent from the main air handling system that serves all other areas of the building and all air within the private room is exhausted directly to the outside by an exhaust fan of sufficient size."
The loophole is already causing confusion and uncertainty, and some restaurants are apparently prepared to establish enclosed smoking areas for their patrons.
The Rest of the Story
Perhaps the folly of public health advocates supporting such an inconsistent approach to the regulation of a supposedly dangerous health hazard is expressed best by one Gainesville restaurant owner, who is quoted in a Gainesville Times article as stating: "I don't like the gray area we have in the law. Either you do or you don't allow smoking."
He's exactly right. As I argued previously, either secondhand smoke is or is not a significant health hazard for which all employees deserve protection. Senate Bill 90 creates an unlevel playing field, in which no employee is guaranteed protection, workers in bars and restaurants are treated differently, workers are treated differently depending on the nature of the patrons they serve and on whether their employers are financially well-off enough to afford the creation of a separately ventilated smoking area.
But loophole 9B could be an extreme problem because it essentially nullifies even the weak health protection that SB90 might otherwise provide. Because there is no size limit on the allowed smoking areas, restaurants may presumably create smoking rooms that take up most of the seating capacity of their establishments. It is even conceivable that the legislation actually allows the designation of an entire restaurant as a smoking room, as long as the room is considered private and is ventilated directly to the outside.
The critical point for interpretation is the meaning of the phrase "private room." Not only is this phrase not defined in the bill, but it is not referring to establishments such as "private clubs" in other legislation, for which there is a definition available in the statutory language that allows the creation and/or licensing of such establishments. Given the absence of any definition for this term, courts are likely to adopt the broadest of possible interpretations, which would essentially mean that a restaurant could create a smoking room that occupies the substantial majority of the seating capacity of the facility.
Because the carcinogen levels in enclosed smoking rooms are extremely high, SB90 represents an extreme health hazard to the employees who will have to serve in such areas. In fact, epidemiologic data suggest that this law will cause more health damage because of the pollution chambers it will create for many restaurant workers than any health benefits it may offer for restaurant workers who are fortunate enough to work in an establishment that cannot afford to create a separately ventilated smoking room. In a 1995 issue of Tobacco Control, I and fellow researchers at CDC estimated that this type of policy will actually cause more deaths than lives saved (see: Siegel M, Husten C, Merritt R, Giovino G, Eriksen M: The health effects of separately ventilated smoking lounges on smokers: Is this an appropriate public health policy? Tobacco Control 1995; 4:22-29).
Thus, the loophole in this legislation could not only nullify the health protections offered to Georgia workers by this bill, it could actually create hazards that did not exist prior to the legislation.
One of the central tenets of medicine and public health is the expression "First, to do no harm." The passage of Georgia's inconsistent and nonsensible workplace smoking law violates this principle of public health practice by creating harm for many of the very workers who this law is supposedly aiming to protect.
While public health practitioners in Georgia are not to blame for the enactment of the law, they still chose to support the law's enactment, despite its inconsistencies, the unlevel playing field it creates, and the harm that it is going to cause for many restaurant workers. I do not think this is the way we should be practicing public health, and I certainly hope that public health advocates in other states will avoid a replay of this saga.
The loophole is exception 9B, which exempts from the smoking law any "private rooms in restaurants and bars if such rooms are enclosed and have an air handling system independent from the main air handling system that serves all other areas of the building and all air within the private room is exhausted directly to the outside by an exhaust fan of sufficient size."
The loophole is already causing confusion and uncertainty, and some restaurants are apparently prepared to establish enclosed smoking areas for their patrons.
The Rest of the Story
Perhaps the folly of public health advocates supporting such an inconsistent approach to the regulation of a supposedly dangerous health hazard is expressed best by one Gainesville restaurant owner, who is quoted in a Gainesville Times article as stating: "I don't like the gray area we have in the law. Either you do or you don't allow smoking."
He's exactly right. As I argued previously, either secondhand smoke is or is not a significant health hazard for which all employees deserve protection. Senate Bill 90 creates an unlevel playing field, in which no employee is guaranteed protection, workers in bars and restaurants are treated differently, workers are treated differently depending on the nature of the patrons they serve and on whether their employers are financially well-off enough to afford the creation of a separately ventilated smoking area.
But loophole 9B could be an extreme problem because it essentially nullifies even the weak health protection that SB90 might otherwise provide. Because there is no size limit on the allowed smoking areas, restaurants may presumably create smoking rooms that take up most of the seating capacity of their establishments. It is even conceivable that the legislation actually allows the designation of an entire restaurant as a smoking room, as long as the room is considered private and is ventilated directly to the outside.
The critical point for interpretation is the meaning of the phrase "private room." Not only is this phrase not defined in the bill, but it is not referring to establishments such as "private clubs" in other legislation, for which there is a definition available in the statutory language that allows the creation and/or licensing of such establishments. Given the absence of any definition for this term, courts are likely to adopt the broadest of possible interpretations, which would essentially mean that a restaurant could create a smoking room that occupies the substantial majority of the seating capacity of the facility.
Because the carcinogen levels in enclosed smoking rooms are extremely high, SB90 represents an extreme health hazard to the employees who will have to serve in such areas. In fact, epidemiologic data suggest that this law will cause more health damage because of the pollution chambers it will create for many restaurant workers than any health benefits it may offer for restaurant workers who are fortunate enough to work in an establishment that cannot afford to create a separately ventilated smoking room. In a 1995 issue of Tobacco Control, I and fellow researchers at CDC estimated that this type of policy will actually cause more deaths than lives saved (see: Siegel M, Husten C, Merritt R, Giovino G, Eriksen M: The health effects of separately ventilated smoking lounges on smokers: Is this an appropriate public health policy? Tobacco Control 1995; 4:22-29).
Thus, the loophole in this legislation could not only nullify the health protections offered to Georgia workers by this bill, it could actually create hazards that did not exist prior to the legislation.
One of the central tenets of medicine and public health is the expression "First, to do no harm." The passage of Georgia's inconsistent and nonsensible workplace smoking law violates this principle of public health practice by creating harm for many of the very workers who this law is supposedly aiming to protect.
While public health practitioners in Georgia are not to blame for the enactment of the law, they still chose to support the law's enactment, despite its inconsistencies, the unlevel playing field it creates, and the harm that it is going to cause for many restaurant workers. I do not think this is the way we should be practicing public health, and I certainly hope that public health advocates in other states will avoid a replay of this saga.
Thursday, May 12, 2005
American Legacy Foundation Tactics to Increase its Funding Exposed
During testimony at today's DOJ tobacco trial, the American Legacy Foundation's inappropriate tactics to increase its funding, reported earlier (post1 post2) here at The Rest of the Story, were publicly exposed. These tactics have included injecting itself as a party into the DOJ trial, using a front group (The Citizens' Commission to Protect the Truth) to create the appearance of independent citizens' support for Legacy funding, and relying upon a legal brief from its front group that has little legal merit but is ostensibly just an attempt to use the DOJ case to try to extract funding for the Foundation.
According to a Dow Jones article, Philip Morris lawyer Dan Webb suggested to the Court that the American Legacy Foundation was "'angling' itself into the government's fraud case against cigarette makers in hopes of obtaining more funding." Webb explained that "ALF began a plan to find a way to leverage its ability to engage in tobacco litigation...and use that as a way to get more money" for the organization.
According to the article, "Legacy testified in written direct that the group, set up in March 1999, 'is facing what can only be called a financial crisis'" but denied that its testimony is motivated by that financial concern, "stating ALF 'has absolutely not been offered anything in return' for its testimony." However, Webb pointed out that "the Citizens Commission to Protect the Truth, which receives much of its funding from ALF, filed a brief asking District Court Judge Gladys Kessler, who is hearing the nonjury trial, to consider long-term, industry-funded youth prevention campaigns through ALF as a remedy, should she rule that tobacco companies fraudulently denied smoking's health risks in the past and are likely to act fraudulently in the future."
The Rest of the Story
Although I disagree with most of Webb's legal arguments in tobacco cases and have personally confronted him and his legal team many times in the courtroom, I think that he is right on the mark in his perception of the American Legacy Foundation's role in the DOJ case. While the Legacy Foundation has possibly succeeded in pulling the wool over the eyes of much of the public health community, its inappropriate, unethical, and shameless tactics were finally exposed publicly in the courtroom by an astute lawyer who could see a spade for a spade.
If my analysis which revealed the lack of a reasonable legal argument in the Citizens' Commission amicus brief was not enough to expose what is really going on here, the proof is in the words of the Commission itself, which, according to its web site, plans to "file amicus briefs in appropriate tobacco litigation. It will ask courts to order tobacco companies to provide funds for the truth® campaign as one of the remedies for tobacco company misconduct."
There is no doubt here about what is going on. The web site does not state that the Citizens' Commission has information that would be valuable and relevant to the Court in certain tobacco litigation and that it therefore will seek amicus status. No - the web site makes it clear that the filing of amicus briefs is merely a strategy to pursue funding for Legacy's truth® campaign.
This is not about the American Legacy Foundation acting in the interest of the public's health. This is not about the Foundation providing valuable and relevant legal arguments. It is clearly about Legacy using the DOJ case as a vehicle to try to increase funding for itself. The end here is not public health or justice; it is simply the securing of funding to continue the "truth" campaign. And the means here is not the appropriate practice of public health; it is the use of deceptive tactics for self-promotion.
The "truth" has finally come out.
According to a Dow Jones article, Philip Morris lawyer Dan Webb suggested to the Court that the American Legacy Foundation was "'angling' itself into the government's fraud case against cigarette makers in hopes of obtaining more funding." Webb explained that "ALF began a plan to find a way to leverage its ability to engage in tobacco litigation...and use that as a way to get more money" for the organization.
According to the article, "Legacy testified in written direct that the group, set up in March 1999, 'is facing what can only be called a financial crisis'" but denied that its testimony is motivated by that financial concern, "stating ALF 'has absolutely not been offered anything in return' for its testimony." However, Webb pointed out that "the Citizens Commission to Protect the Truth, which receives much of its funding from ALF, filed a brief asking District Court Judge Gladys Kessler, who is hearing the nonjury trial, to consider long-term, industry-funded youth prevention campaigns through ALF as a remedy, should she rule that tobacco companies fraudulently denied smoking's health risks in the past and are likely to act fraudulently in the future."
The Rest of the Story
Although I disagree with most of Webb's legal arguments in tobacco cases and have personally confronted him and his legal team many times in the courtroom, I think that he is right on the mark in his perception of the American Legacy Foundation's role in the DOJ case. While the Legacy Foundation has possibly succeeded in pulling the wool over the eyes of much of the public health community, its inappropriate, unethical, and shameless tactics were finally exposed publicly in the courtroom by an astute lawyer who could see a spade for a spade.
If my analysis which revealed the lack of a reasonable legal argument in the Citizens' Commission amicus brief was not enough to expose what is really going on here, the proof is in the words of the Commission itself, which, according to its web site, plans to "file amicus briefs in appropriate tobacco litigation. It will ask courts to order tobacco companies to provide funds for the truth® campaign as one of the remedies for tobacco company misconduct."
There is no doubt here about what is going on. The web site does not state that the Citizens' Commission has information that would be valuable and relevant to the Court in certain tobacco litigation and that it therefore will seek amicus status. No - the web site makes it clear that the filing of amicus briefs is merely a strategy to pursue funding for Legacy's truth® campaign.
This is not about the American Legacy Foundation acting in the interest of the public's health. This is not about the Foundation providing valuable and relevant legal arguments. It is clearly about Legacy using the DOJ case as a vehicle to try to increase funding for itself. The end here is not public health or justice; it is simply the securing of funding to continue the "truth" campaign. And the means here is not the appropriate practice of public health; it is the use of deceptive tactics for self-promotion.
The "truth" has finally come out.
Georgia Smokefree Air Act of 2005 Signed into Law: Misperceptions Abound
The Georgia Smokefree Air Act of 2005 was signed by Governor Sonny Perdue Tuesday, and will become effective on July 1. The bill has been described in the media as a widespread "smoking ban" that leaves only a "handful" of public places where smoking will still be allowed. It has also been described as a "public health measure," and as a great "success" for the state of Georgia.
The Rest of the Story
First, it is important to be clear about what the Georgia law does and does not do. It does not ban smoking in all bars and restaurants. It does not ban smoking in all restaurants. It does not ban smoking in all restaurants at which minors are allowed.
What it does is restrict smoking in restaurants at which minors are allowed to enclosed, separately ventilated areas of any size, in which employees work, with no restrictions on smoking in adult-only restaurants or bars. As I have documented, the levels of secondhand smoke in the newly-created separately ventilated smoking areas are going to be extremely high and are likely to cause severe, adverse health effects for the unfortunate restaurant workers who are forced to work in such areas (see: Siegel M, Husten C, Merritt R, Giovino G, Eriksen M: The health effects of separately ventilated smoking lounges on smokers: Is this an appropriate public health policy? Tobacco Control 1995; 4:22-29).
So this is hardly a widespread smoking ban and it hardly leaves just a "handful" of public places where people can smoke.
Second, while the original bill introduced into the legislature was a public health measure, I don't view this highly contrived patchwork of legislation that guarantees protection to not a single worker in the state of Georgia to be a public health measure.
First of all, it is not designed to protect people from secondhand smoke. It specifically chooses to protect only youths from secondhand smoke and to exclude adults from such protection. I don't see any public health rationale behind an approach that is based on a premise that carcinogens are very bad for kids but acceptable for adults.
Second of all, it is not designed to protect workers from secondhand smoke, just patrons. But patrons can choose to eat at a smoke-free restaurant if they want. We don't really need the legislature to intervene to create more smoke-free choices for customers. If we need anything, it is for the legislature to intervene to ensure a smoke-free working environment for all employees. I simply don't see a strong public health rationale behind an approach that is based on a premise that carcinogens are very bad for customers, but acceptable for workers.
Finally, I don't see this bill as a "success." If anything, I'm afraid it may hurt long-term efforts to promote and ensure a safe working environment for citizens in Georgia and elsewhere by framing the problem of secondhand smoke exposure in two unfortunate ways:
1) The bill clearly frames secondhand smoke as a problem of youths, but not adults. The whole focus on restricting smoking only insofar as to protect youths from being exposed is based not on any defensible public health rationale, but more on some sort of political feasibility rationale. I think it does damage, because it sends the message that secondhand smoke exposure is only a problem insofar as it affects youths. The very message that is sends condones and institutionalizes adult exposure to carcinogens as an acceptable way of life.
2) The bill clearly frames secondhand smoke as a problem of customers, but not workers. The whole focus on restricting smoking only insofar as to protect customers from being exposed is based not on any defensible public health rationale, but also on some sort of political feasibility criterion. In fact, it is the workers who need the protection the most - not the customers. While the customers may be present for a couple of hours at a time, workers are likely there for 40 or more hours per week.
I am seriously concerned about how the framing of this legislation is going to affect efforts in other states. By creating this youth-only focus, I'm afraid the Georgia experience is going to give legislators in other states a nice political out that they may not have previously had. If this approach spreads beyond the Peach State, it will be a public health disaster. First, because lots of opportunities to provide real, guaranteed protection for all citizens - adults and kids alike - and for employees as well as patrons will go down the wayside. Second, because this inconsistent and largely unjustified public health approach makes public health practitioners everywhere look as if we do not really stand for any solid principles, but are just trying to interfere with people smoking as much as possible.
That's not what I'm in this for. I'm in this to try to save lives and reduce morbidity and suffering. And taken as a whole, I do not think Georgia's Smokefree Air Act of 2005 will do either.
The Rest of the Story
First, it is important to be clear about what the Georgia law does and does not do. It does not ban smoking in all bars and restaurants. It does not ban smoking in all restaurants. It does not ban smoking in all restaurants at which minors are allowed.
What it does is restrict smoking in restaurants at which minors are allowed to enclosed, separately ventilated areas of any size, in which employees work, with no restrictions on smoking in adult-only restaurants or bars. As I have documented, the levels of secondhand smoke in the newly-created separately ventilated smoking areas are going to be extremely high and are likely to cause severe, adverse health effects for the unfortunate restaurant workers who are forced to work in such areas (see: Siegel M, Husten C, Merritt R, Giovino G, Eriksen M: The health effects of separately ventilated smoking lounges on smokers: Is this an appropriate public health policy? Tobacco Control 1995; 4:22-29).
So this is hardly a widespread smoking ban and it hardly leaves just a "handful" of public places where people can smoke.
Second, while the original bill introduced into the legislature was a public health measure, I don't view this highly contrived patchwork of legislation that guarantees protection to not a single worker in the state of Georgia to be a public health measure.
First of all, it is not designed to protect people from secondhand smoke. It specifically chooses to protect only youths from secondhand smoke and to exclude adults from such protection. I don't see any public health rationale behind an approach that is based on a premise that carcinogens are very bad for kids but acceptable for adults.
Second of all, it is not designed to protect workers from secondhand smoke, just patrons. But patrons can choose to eat at a smoke-free restaurant if they want. We don't really need the legislature to intervene to create more smoke-free choices for customers. If we need anything, it is for the legislature to intervene to ensure a smoke-free working environment for all employees. I simply don't see a strong public health rationale behind an approach that is based on a premise that carcinogens are very bad for customers, but acceptable for workers.
Finally, I don't see this bill as a "success." If anything, I'm afraid it may hurt long-term efforts to promote and ensure a safe working environment for citizens in Georgia and elsewhere by framing the problem of secondhand smoke exposure in two unfortunate ways:
1) The bill clearly frames secondhand smoke as a problem of youths, but not adults. The whole focus on restricting smoking only insofar as to protect youths from being exposed is based not on any defensible public health rationale, but more on some sort of political feasibility rationale. I think it does damage, because it sends the message that secondhand smoke exposure is only a problem insofar as it affects youths. The very message that is sends condones and institutionalizes adult exposure to carcinogens as an acceptable way of life.
2) The bill clearly frames secondhand smoke as a problem of customers, but not workers. The whole focus on restricting smoking only insofar as to protect customers from being exposed is based not on any defensible public health rationale, but also on some sort of political feasibility criterion. In fact, it is the workers who need the protection the most - not the customers. While the customers may be present for a couple of hours at a time, workers are likely there for 40 or more hours per week.
I am seriously concerned about how the framing of this legislation is going to affect efforts in other states. By creating this youth-only focus, I'm afraid the Georgia experience is going to give legislators in other states a nice political out that they may not have previously had. If this approach spreads beyond the Peach State, it will be a public health disaster. First, because lots of opportunities to provide real, guaranteed protection for all citizens - adults and kids alike - and for employees as well as patrons will go down the wayside. Second, because this inconsistent and largely unjustified public health approach makes public health practitioners everywhere look as if we do not really stand for any solid principles, but are just trying to interfere with people smoking as much as possible.
That's not what I'm in this for. I'm in this to try to save lives and reduce morbidity and suffering. And taken as a whole, I do not think Georgia's Smokefree Air Act of 2005 will do either.
New Lung Cancer Alliance Ad Campaign Trying to Dissociate Lung Cancer from Smoking
Rivka Weiser of the American Council on Science and Health has exposed a new advertising campaign by the Lung Cancer Alliance -- a national nonprofit organization dedicated to advocating for people living with or at risk for lung cancer -- to try to increase funding for lung cancer research by emphasizing that most patients who are diagnosed with lung cancer are not smokers. The advertisement, featured in Tuesday's New York Times, has a picture of a lung cancer victim with the text: "This lung cancer patient can't stop smoking. Because she never started."
The main ad text states: "There’s no question that millions of lung cancer patients have died because of smoking. But it’s also true that over 50 percent of the people now being diagnosed with lung cancer are non-smokers or former smokers. In spite of this, the stigma of smoking
is still so great that lung cancer is underfunded, under-researched, and generally ignored by Congress." It concludes: "It’s time to treat lung cancer research with the same urgency that we bring to every other major cancer. Because the most lethal cancer in the country can no longer be hidden behind a smoke screen."
The Rest of the Story
While the goal of this ad campaign is laudable and more federal funding should be placed into lung cancer research, including its prevention, detection, treatment, and cure, I agree with Weiser that the advertisement may be misleading to the public. The ad headline refers to an individual whose lung cancer is unrelated to active smoking. But the subsequent text lumps together nonsmokers and ex-smokers in order to be able to attribute the appearance (i.e., diagnosis) of lung cancer to people who do not smoke. Thus, the reader is, I think, led to believe that the majority of lung cancer cases are unrelated to smoking. This is quite misleading, as 85% of lung cancers are attributable to smoking.
Presumably, the premise of the ad is that lung cancer is underfunded because smoking has a stigma attached to it and since most lung cancer is associated in the public eye with smoking, the disease as a whole is viewed as basically a disease of smoking and therefore the smoking-related stigma is hurting lung cancer research funding. So to avoid this problem, the ad aims to dissociate lung cancer somewhat from smoking. It aims to portray lung cancer as something other than a smoking-related disease. It aims to avoid the smoking-related stigma and thus increase funding for lung cancer.
Unfortunately, I believe both the means and the ends of this approach are flawed. The means are problematic because however important lung cancer research may be, it does not seem appropriate to use an approach based on misleading people to achieve that end.
The ends themselves, however, are flawed in two ways. First, by working to dissociate the public perception of an integral link between smoking and lung cancer, the ad is undermining decades of efforts of public health professionals and organizations to establish a clear association between smoking and lung cancer in the public's mind (which is essential, since lung cancer is an epidemic caused by smoking and a clear public perception of the overwhelming link between smoking and lung cancer is essential for efforts to prevent and reduce smoking). Thus, the overall message is inconsistent with public health efforts to tie lung cancer and smoking inextricably in the public's mind. At worst, the ad is reminiscent of tobacco industry efforts in the past to undermine the link between smoking and lung cancer. Although this was obviously not the goal, the fact that the ad may have this unintended consequence suggests that the approach taken in the campaign is not appropriate.
Second, by implying that funding for lung cancer research is justified specifically because most people affected do not currently smoke, the ad actually increases, rather than decreases the stigma associated with smoking and reinforces, rather than dubunks the view that funding of research for diseases should be based on the overall impact of the disease and not on how society views the behaviors or other factors associated with the disease.
So instead of saying, "Hey - smokers are human beings who have equal right to research and treatment for their diseases regardless of whether smoking is viewed as being socially acceptable," the ad is basically taking as a premise the fact that smokers are somehow lower-class citizens and their diseases are not equally deserving of research and treatment, but "Hey - most people who are diagnosed with lung cancer don't smoke at the time of diagnosis, so can't we just ignore the fact that they probably smoked in the past?"
There is no reason why society should devote less research funding to smoking-related diseases because they are caused by an unpopular behavior, nor is there any reason not to devote research funding to AIDS due to the stigma associated with the behavioral risk factors for that disease, nor should we reduce research funding for any disease because of any stigma attached to its underlying risk factors. It's time to end the stigma - period. Or at least to force policy makers to ignore societal stigma in making their funding decisions.
Feeding into these destructive stigmas may have short-term funding appeal, but I do not think it is the best long-term solution.
The main ad text states: "There’s no question that millions of lung cancer patients have died because of smoking. But it’s also true that over 50 percent of the people now being diagnosed with lung cancer are non-smokers or former smokers. In spite of this, the stigma of smoking
is still so great that lung cancer is underfunded, under-researched, and generally ignored by Congress." It concludes: "It’s time to treat lung cancer research with the same urgency that we bring to every other major cancer. Because the most lethal cancer in the country can no longer be hidden behind a smoke screen."
The Rest of the Story
While the goal of this ad campaign is laudable and more federal funding should be placed into lung cancer research, including its prevention, detection, treatment, and cure, I agree with Weiser that the advertisement may be misleading to the public. The ad headline refers to an individual whose lung cancer is unrelated to active smoking. But the subsequent text lumps together nonsmokers and ex-smokers in order to be able to attribute the appearance (i.e., diagnosis) of lung cancer to people who do not smoke. Thus, the reader is, I think, led to believe that the majority of lung cancer cases are unrelated to smoking. This is quite misleading, as 85% of lung cancers are attributable to smoking.
Presumably, the premise of the ad is that lung cancer is underfunded because smoking has a stigma attached to it and since most lung cancer is associated in the public eye with smoking, the disease as a whole is viewed as basically a disease of smoking and therefore the smoking-related stigma is hurting lung cancer research funding. So to avoid this problem, the ad aims to dissociate lung cancer somewhat from smoking. It aims to portray lung cancer as something other than a smoking-related disease. It aims to avoid the smoking-related stigma and thus increase funding for lung cancer.
Unfortunately, I believe both the means and the ends of this approach are flawed. The means are problematic because however important lung cancer research may be, it does not seem appropriate to use an approach based on misleading people to achieve that end.
The ends themselves, however, are flawed in two ways. First, by working to dissociate the public perception of an integral link between smoking and lung cancer, the ad is undermining decades of efforts of public health professionals and organizations to establish a clear association between smoking and lung cancer in the public's mind (which is essential, since lung cancer is an epidemic caused by smoking and a clear public perception of the overwhelming link between smoking and lung cancer is essential for efforts to prevent and reduce smoking). Thus, the overall message is inconsistent with public health efforts to tie lung cancer and smoking inextricably in the public's mind. At worst, the ad is reminiscent of tobacco industry efforts in the past to undermine the link between smoking and lung cancer. Although this was obviously not the goal, the fact that the ad may have this unintended consequence suggests that the approach taken in the campaign is not appropriate.
Second, by implying that funding for lung cancer research is justified specifically because most people affected do not currently smoke, the ad actually increases, rather than decreases the stigma associated with smoking and reinforces, rather than dubunks the view that funding of research for diseases should be based on the overall impact of the disease and not on how society views the behaviors or other factors associated with the disease.
So instead of saying, "Hey - smokers are human beings who have equal right to research and treatment for their diseases regardless of whether smoking is viewed as being socially acceptable," the ad is basically taking as a premise the fact that smokers are somehow lower-class citizens and their diseases are not equally deserving of research and treatment, but "Hey - most people who are diagnosed with lung cancer don't smoke at the time of diagnosis, so can't we just ignore the fact that they probably smoked in the past?"
There is no reason why society should devote less research funding to smoking-related diseases because they are caused by an unpopular behavior, nor is there any reason not to devote research funding to AIDS due to the stigma associated with the behavioral risk factors for that disease, nor should we reduce research funding for any disease because of any stigma attached to its underlying risk factors. It's time to end the stigma - period. Or at least to force policy makers to ignore societal stigma in making their funding decisions.
Feeding into these destructive stigmas may have short-term funding appeal, but I do not think it is the best long-term solution.
Tuesday, May 10, 2005
Update: American Legacy Foundation Award to Time Inc. Encouraging Progress, As Promised
This week's issue of Sports Illustrated, a Time Inc. publication, demonstrates tremendous progress regarding cigarette advertising. Perhaps this is the progress that the American Legacy Foundation spoke of when it defended its award to Time Inc. by claiming that the award was to "encourage progress" rather than "reward success."
The Rest of the Story
The progress displayed in this week's Sports Illustrated is one of the most beautiful, clever, attractive, and youth-appealing cigarette magazine advertisements I have ever seen: a four-page spread for Camel Turkish Silver, described as "the mellowist" Camel ever.
I hope that the American Legacy Foundation is taking some pride in this tremendous accomplishment for the youth of America by Legacy's number one corporate partner.
Congratulations to Time Inc. and the American Legacy Foundation: corporate partners and modern heroes in tobacco control!
The Rest of the Story
The progress displayed in this week's Sports Illustrated is one of the most beautiful, clever, attractive, and youth-appealing cigarette magazine advertisements I have ever seen: a four-page spread for Camel Turkish Silver, described as "the mellowist" Camel ever.
I hope that the American Legacy Foundation is taking some pride in this tremendous accomplishment for the youth of America by Legacy's number one corporate partner.
Congratulations to Time Inc. and the American Legacy Foundation: corporate partners and modern heroes in tobacco control!
Monday, May 09, 2005
Saturday, May 07, 2005
Campaign for Tobacco-Free Kids Continues to Mislead the Public about Flawed FDA Bill; This Time, University of Minnesota Report is the Stimulus
In a press release issued Wednesday, the Campaign for Tobacco-Free Kids used the results of a University of Minnesota report on potential reduced exposure products (PREPS) to support the current FDA tobacco legislation that is pending in Congress. The Campaign relied upon two key findings of the report -- its conclusion that there is no evidence any current PREPS actually reduce disease risk and its assertion that regulation of tobacco products is necessary to prevent unsubstantiated health claims regarding PREPS -- to support its promotion not only of the idea of regulation of tobacco products, but specifically its promotion of FDA regulation of tobacco under S.666 and H.R.1376.
In the release, the Campaign states: "this legislation would prohibit any health claims about tobacco products unless the FDA determines both that these claims are scientifically substantiated and that they would not discourage current tobacco users from quitting or encourage new users to start." The Campaign also states that the legislation would give FDA the authority to "crack down on tobacco marketing and sales to kids," and "require changes in tobacco products to make them less harmful."
The Rest of the Story
What is most interesting about the Campaign's press release is not what it says, but what it hides from the reader.
First, the Campaign claims that the FDA legislation would prohibit health claims about reduced exposure products unless the FDA determines that these claims are scientifically substantiated. However, if one reads the actual bill, it is clear that reduced exposure products can make health claims without scientific substantiation of actual health benefits. The legislation (under section 901[g][2][B]) merely requires that two criteria be met:
The second criterion, that a tobacco company must anticipate that a product would, in the future, result in a health benefit, is equally easy to meet. After all, the word "anticipate" is defined in this context as "to expect." So all a tobacco company has to do is state that it "expects" a health benefit in the future and it has basically met this criterion. How easy is it going to be for a public health group to demonstrate that in fact, a tobacco company does not expect a health benefit?
The problem is that the Campaign for Tobacco-Free Kids is relying upon one small provision in the legislation that dictates reduced risk claims (section 901[g][1]), but largely ignoring a separate provision that applies to reduced exposure claims (section 901[g][2]). In fact, 901(g)(2) allows reduced exposure claims to be made with little, if any, substantiation of a health benefit.
Second, the Campaign claims that the FDA legislation would allow reduced exposure health claims to be made only if they "would not discourage current tobacco users from quitting or encourage new users to start." But the actual legislation (section 901[g][2][B][iv]) requires merely that: "approval of the application is expected to benefit the health of the population as a whole taking into account both users of tobacco products and persons who do not currently use tobacco products."
Thus, a tobacco company merely has to show that the benefits of a potentially reduced risk product in terms of future health are expected to outweight any costs related to smokers being less likely to quit or youths being more likely to start because of the reduced risk product being available. NOWHERE in the legislation does it state that such a health claim can be made only if the claim would not discourage smokers from quitting or encourage youths to start.
The Campaign has completely pulled that out of the blue, and they are using it to try to pull the wool over the eyes of the public as well as their own constituents. This is not only inaccurate and misleading, but it is disingenuous and does a disservice to thousands of tobacco control and public health advocates who are relying on the Campaign for some semblance of an accurate and objective accounting of the legislation.
Third, the Campaign claims that the legislation would give FDA the power to crack down on marketing to youths. However, the Campaign fails to inform the public that the Supreme Court of the United States has made it clear that any broad advertising regulation, such as would be necessary to "crack down" on marketing to youths, is likely to be viewed as violating the freedom of speech provisions of the First Amendment to the United States Constitution.
I find it misleading and disingenous for the Campaign to make promises about the power this legislation is going to give to FDA to curtail advertising when the truth is that there is likely very little substantial impact that FDA could have on such advertising given the limitations of the Supreme Court's holdings. Unless the Campaign can either change the United States Constitution or change the interpretation of Constitutional law, then it should cease and desist from making claims to the public and to public health advocates that are simply not reasonable.
Finally, the Campaign claims that the legislation would give FDA authority to "require changes in tobacco products to make them less harmful." However, the Campaign has failed to suggest even one change that it would recommend and to provide any evidence that such a change would actually result in a safer product. Until and unless the Campaign can provide some evidence for the health impact of a specific recommended performance standard it should cease and desist from making what amount to unsubstantiated health claims of its own.
The rest of the story reveals that the Campaign for Tobacco-Free Kids - an organization which is relentlessly criticizing the tobacco companies for making misleading claims - is itself making a continuing string of misleading, inaccurate, unsubstantiated, and disingenous claims about what the FDA tobacco legislation does.
What possible credibility will the Campaign have to question the misleading claims of the tobacco industry if it continues its pattern of widespread deception of the public and of its own constituents about the FDA tobacco legislation?
I suggest it will lose all credibility, unless the Campaign immediately ceases and desists from its continued misleading, inaccurate, and disingenuous claims about this harmful and severely flawed FDA tobacco legislation.
In the release, the Campaign states: "this legislation would prohibit any health claims about tobacco products unless the FDA determines both that these claims are scientifically substantiated and that they would not discourage current tobacco users from quitting or encourage new users to start." The Campaign also states that the legislation would give FDA the authority to "crack down on tobacco marketing and sales to kids," and "require changes in tobacco products to make them less harmful."
The Rest of the Story
What is most interesting about the Campaign's press release is not what it says, but what it hides from the reader.
First, the Campaign claims that the FDA legislation would prohibit health claims about reduced exposure products unless the FDA determines that these claims are scientifically substantiated. However, if one reads the actual bill, it is clear that reduced exposure products can make health claims without scientific substantiation of actual health benefits. The legislation (under section 901[g][2][B]) merely requires that two criteria be met:
- "scientific evidence is not available and, using the best available scientific methods, cannot be made available without conducting long-term epidemiological studies for an application to meet the standards set forth in paragraph (1);" and
- "the scientific evidence that is available without conducting long-term epidemiological studies demonstrates that a measurable and substantial reduction in morbidity or mortality among individual tobacco users is anticipated in subsequent studies."
The second criterion, that a tobacco company must anticipate that a product would, in the future, result in a health benefit, is equally easy to meet. After all, the word "anticipate" is defined in this context as "to expect." So all a tobacco company has to do is state that it "expects" a health benefit in the future and it has basically met this criterion. How easy is it going to be for a public health group to demonstrate that in fact, a tobacco company does not expect a health benefit?
The problem is that the Campaign for Tobacco-Free Kids is relying upon one small provision in the legislation that dictates reduced risk claims (section 901[g][1]), but largely ignoring a separate provision that applies to reduced exposure claims (section 901[g][2]). In fact, 901(g)(2) allows reduced exposure claims to be made with little, if any, substantiation of a health benefit.
Second, the Campaign claims that the FDA legislation would allow reduced exposure health claims to be made only if they "would not discourage current tobacco users from quitting or encourage new users to start." But the actual legislation (section 901[g][2][B][iv]) requires merely that: "approval of the application is expected to benefit the health of the population as a whole taking into account both users of tobacco products and persons who do not currently use tobacco products."
Thus, a tobacco company merely has to show that the benefits of a potentially reduced risk product in terms of future health are expected to outweight any costs related to smokers being less likely to quit or youths being more likely to start because of the reduced risk product being available. NOWHERE in the legislation does it state that such a health claim can be made only if the claim would not discourage smokers from quitting or encourage youths to start.
The Campaign has completely pulled that out of the blue, and they are using it to try to pull the wool over the eyes of the public as well as their own constituents. This is not only inaccurate and misleading, but it is disingenuous and does a disservice to thousands of tobacco control and public health advocates who are relying on the Campaign for some semblance of an accurate and objective accounting of the legislation.
Third, the Campaign claims that the legislation would give FDA the power to crack down on marketing to youths. However, the Campaign fails to inform the public that the Supreme Court of the United States has made it clear that any broad advertising regulation, such as would be necessary to "crack down" on marketing to youths, is likely to be viewed as violating the freedom of speech provisions of the First Amendment to the United States Constitution.
I find it misleading and disingenous for the Campaign to make promises about the power this legislation is going to give to FDA to curtail advertising when the truth is that there is likely very little substantial impact that FDA could have on such advertising given the limitations of the Supreme Court's holdings. Unless the Campaign can either change the United States Constitution or change the interpretation of Constitutional law, then it should cease and desist from making claims to the public and to public health advocates that are simply not reasonable.
Finally, the Campaign claims that the legislation would give FDA authority to "require changes in tobacco products to make them less harmful." However, the Campaign has failed to suggest even one change that it would recommend and to provide any evidence that such a change would actually result in a safer product. Until and unless the Campaign can provide some evidence for the health impact of a specific recommended performance standard it should cease and desist from making what amount to unsubstantiated health claims of its own.
The rest of the story reveals that the Campaign for Tobacco-Free Kids - an organization which is relentlessly criticizing the tobacco companies for making misleading claims - is itself making a continuing string of misleading, inaccurate, unsubstantiated, and disingenous claims about what the FDA tobacco legislation does.
What possible credibility will the Campaign have to question the misleading claims of the tobacco industry if it continues its pattern of widespread deception of the public and of its own constituents about the FDA tobacco legislation?
I suggest it will lose all credibility, unless the Campaign immediately ceases and desists from its continued misleading, inaccurate, and disingenuous claims about this harmful and severely flawed FDA tobacco legislation.
Wednesday, May 04, 2005
FDA Tobacco Regulation: Opportunity or Diversion for the Next Decade?
At an opening round session at the 2005 National Tobacco Control Conference in Chicago this morning, more than 100 tobacco control practitioners gathered to take part in what was perhaps the first public discussion of the proposed FDA tobacco legislation among grassroots public health advocates. Based on a critical evaluation of the FDA legislation by a panel of expert medical and public health researchers and practitioners, there was a general consensus that enactment of this legislation would have a substantial detrimental impact on the public's health and that the bill is therefore an inappropriate public health measure that we in tobacco control should not support. The panel concluded that rather than being an opportunity for progress, the bill is a diversion from what tobacco control organizations should be doing.
I opened the session by outlining the benefits and costs of the proposed legislation:
BENEFITS
On the benefit side, the bill would require larger and stronger warning labels on cigarette packages and advertisements. However, there are no other significant benefits.
While some have argued that the bill would help curtail tobacco advertising and marketing to youths, it is unlikely that any substantial restrictions on cigarette advertising would meet the requirements set out by the Supreme Court for complying with the First Amendment's protection of free speech.
While some have argued that requiring disclosure of ingredients and smoke constituents along with giving FDA the authority to set performance standards that eliminate specific constituents would save lives, I pointed out that there is no evidence that removing a few of the more than 4000 chemicals and more than 40 carcinogens would result in a safer product. I also pointed out how absurd such an approach is from a public health perspective.
Finally, while some have argued that the modified risk section of the bill would prevent the marketing of potential reduced exposure products without adequate substantiation and enhance the availability of true reduced risk products whose health benefits are substantiated, I pointed out that the language of the bill actually makes it easier for companies to make a reduced exposure claim with almost no substantiation of health benefits and that the bill essentially puts an end to any possibility of truly reduced risk products by creating an impossible set of standards that such a product must meet.
COSTS
The bill would have a number of substantial deleterious effects:
First, it would create an FDA "stamp of approval" for tobacco products, which would likely decrease the public's perception of the inherent harm of tobacco products. By officially sanctioning the products, the government would be giving the public a false perception of a level of safety.
Second, it would create a perception that the tobacco problem has been taken care of, and no further interventions are necessary. It would become almost impossible to convince state legislators, for example, to allocate substantial funds for tobacco control once FDA is given authority to regulate the product.
Third, it would essentially end tobacco litigation, by allowing the cigarette companies to argue (correctly) that they have already submitted to FDA regulation and so no further punitive or injunctive relief is required. If this legislation is enacted prior to the resolution of the DOJ tobacco lawsuit, it will completely decimate that lawsuit.
Fourth, it would produce an enormous amount of goodwill for the tobacco companies by enabling them to tell the public (accurately) that they now fully comply with a comprehensive system of federal regulation of their products.
In addition, the bill contains loopholes that would make it impossible for FDA to set any truly meaningful performance standards, allow the tobacco companies to tie up in court for years any attempt to require the removal of nicotine from cigarettes, preclude FDA from increasing the age of purchase for tobacco or banning the sale of tobacco in any specific type of retail establishment, and give Congress the ability to overturn any FDA rule that it doesn't like within 60 days, using a short-circuited legislative process that makes it easy, rather than difficult to overturn scientifically-justified regulations solely on political grounds.
A summary of my presentation is available.
Bill Godshall, Executive Director of Smokefree Pennsylvania, followed by focusing on the issue of harm reduction, concluding that the proposed FDA legislation would prevent potentially useful public health approaches to harm reduction in tobacco control.
Dr. Michael Cummings, Senior Research Scientist at Roswell Park Cancer Institute, then pointed out that the FDA legislation focuses on tobacco product toxicity, rather than on how product design changes may influence smoking behavior. True benefits from any regulatory approach would come not from performance standards, he said, but from product design requirements that would lead to decreases in cigarette consumption and smoking prevalence.
Finally, Dr. Alan Blum, Director of the Center for the Study of Tobacco and Society at the University of Alabama, presented a brief history of FDA regulation of pharmaceutical products and questioned whether given the FDA's dismal record in that area, the FDA is an agency that we want to be entrusted with regulation of the nation's most hazardous consumer product in the first place.
The Rest of the Story
The tragedy of this story is not in what happened, but in what did not and is not happening. The major organizations supporting the FDA tobacco legislation, including the Campaign for Tobacco-Free Kids, American Cancer Society, American Heart Association, and American Lung Association, have consistently failed to enter into a dialogue with the public health community on the serious flaws, limitations, and costs of the FDA legislation that I and others have brought to their attention and to the attention of the tobacco control community at large.
According to at least one conference participant at the session, the approach of these organizations has been to simply cast off these criticisms of the legislation as coming from one "misinformed" individual. But there has yet to be any serious attempt to address the substantive issues raised.
There are only two possible reasons I can think of for why these organizations refuse to acknowledge these issues and to entertain any discussion about them, and I do not know if either is correct.
One possibility is that they realize they are wrong and have made a huge mistake in offering to make these concessions to Philip Morris, but are hoping that they can get away with it and can distract enough tobacco control practitioners at the grassroots level so that they will not be questioned in a way that could threaten the deal that has apparently been agreed to. This is actually the better of the two possibilities I can think of.
Another possibility is that they actually believe they are right. But if that is the case, then it is inexcusable that they would not be willing to enter into a discussion of these serious issues with their constituents. After all, they do not run the movement. We are all supposed to be part of the movement, and I think all of us have the right to have our concerns addressed.
Well, after today, one thing is for sure. We're not talking about one "misinformed" individual. There are more than 100 public health practitioners out there who are well aware of what this bill would do and what it would not do. It is going to be increasingly difficult for the Campaign for Tobacco-Free Kids to deflect continued criticism of its support for this legislation by casting the criticism as coming from one individual. And if reading the bill in its entirety constitutes "misinformed," then perhaps that may be a clue as to what the Campaign wants: blind followers who will take their word for the efficacy of the legislation but not dare read the actual bill to find out the true dangers that lurk beneath.
Monday, May 02, 2005
New Study Reports Higher Rates of Suicidal Ideation and Suicide Attempts in Smokers: More Reason to Fire Them?
A study published in the March issue of Archives of General Psychiatry reported that current daily cigarette smokers were almost twice as likely to have suicidal thoughts or a suicide attempt over a ten-year follow-up period, controlling for baseline history of depression and other psychiatric disorders, baseline suicidal ideation, and baseline history of substance abuse (see Breslau N, Schultz LR, Johnson EO Peterson DL, Davis GC. Smoking and the risk of suicidal behavior: A prospective study of a community sample. Archives of General Psychiatry 2005; 62:328-334).
While previous studies had noted a link between smoking and both depression and suicidal thoughts and behavior, this is one of the first longitudinal studies to control for baseline history of depression and substance abuse, as well as for depression and substance abuse that was observed during the first two follow-up assessments. While the authors urge caution in drawing a causal conclusion -- that is, in concluding that smoking was a cause of the suicidal ideation and suicide attempts -- the extent to which the authors controlled for potential confounders certainly suggests that smoking may be an independent cause of suicidal behavior. Regardless of the validity of any causal conclusion, this study confirms that current daily smoking is a significant predictor of subsequent suicidal ideation and behavior.
The Rest of the Story
Combine this news that smoking predicts suicidal risk with other recent evidence that smoking predicts risk of attrition on the job and anti-smoking activists now have powerful data with which to defend employer policies that refuse to hire or that fire smokers for reasons other than the smoking having a direct impact on job performance or being inconsistent with the company's mission. After all, there is no greater form of attrition than death, and the costs of having to replace such an employee are likely to be quite high. Is it not then fair game for an employer to avoid these significant potential costs by refusing to hire persons who are at a clearly identified increased risk: namely, current smokers?
While it may be legal, that does not mean it is right. While it may be economically justifiable, that does not mean it is justified. And while it may make sense to tobacco control advocates to support such policies, that does not mean that it is sensible from a public health perspective.
There are three lines of analysis that I think are essential here:
First, one must consider what factors appropriately play into a decision about employment policies. Some have argued that economic factors are predominant: i.e., if smokers carry with them increased employer costs, then it is justified to not hire them, or to fire them if they are already employed and refuse to (or are unable to) quit. But I do not view employment decisions as being strictly economic ones. There are a host of factors that can and should play into these decisions, including not only economic impacts, but social factors as well, such as the potential impact on smokers as a social class if smoking comes to be synonymous with unemployability.
This is, I think, a serious concern. It will only take a few large employers to adopt such policies before smokers begin to feel the impact in terms of the employment choices that are available to them. And unfortunately, because smoking tends to be somewhat associated with lower income and highly associated with lower levels of education, this does become an issue of social class.
Further, one must consider the question of what other employment restrictions could be justified on similar economic grounds. Suicide has been shown to be associated with unwanted pregnancies and with having a family member who has committed suicide, but does that justify refusing to hire anyone who has ever had an unwanted pregnancy or who has ever had a family member commit suicide?
Second, one must consider what are the potential approaches to the problem? Certainly refusing to hire smokers is one of them. But isn't another approach to hire people on the basis of factors that are directly relevant to their job performance and then to implement employee assistance programs that work with employees to address factors such as smoking, physical health, and mental and emotional health and well-being? From a public health perspective, this second approach is far more sensible, compassionate, and defensible.
Third, I think it is important to note that these concerns apply equally well to problems such as attrition and absenteeism as they do to the issue of suicide risk. There really isn't much of a qualitative difference: absenteeism is a sort of partial attrition and suicide is basically complete and irreversible attrition. All the above arguments still hold with respect to economic concerns regarding employee absenteeism and attrition.
Finally, I should reiterate that I am not suggesting that it is inappropriate for employers to consider smoking as a factor in employment decisions when the smoking directly affects job performance or is inconsistent with a company mission. But I am suggesting that absent those concerns, if it is simply an issue of increased economic costs to the employer, I do not think it is sensible, compassionate, or justifiable for public health practitioners to support policies that make it more difficult for smokers to be employed in our society.
While previous studies had noted a link between smoking and both depression and suicidal thoughts and behavior, this is one of the first longitudinal studies to control for baseline history of depression and substance abuse, as well as for depression and substance abuse that was observed during the first two follow-up assessments. While the authors urge caution in drawing a causal conclusion -- that is, in concluding that smoking was a cause of the suicidal ideation and suicide attempts -- the extent to which the authors controlled for potential confounders certainly suggests that smoking may be an independent cause of suicidal behavior. Regardless of the validity of any causal conclusion, this study confirms that current daily smoking is a significant predictor of subsequent suicidal ideation and behavior.
The Rest of the Story
Combine this news that smoking predicts suicidal risk with other recent evidence that smoking predicts risk of attrition on the job and anti-smoking activists now have powerful data with which to defend employer policies that refuse to hire or that fire smokers for reasons other than the smoking having a direct impact on job performance or being inconsistent with the company's mission. After all, there is no greater form of attrition than death, and the costs of having to replace such an employee are likely to be quite high. Is it not then fair game for an employer to avoid these significant potential costs by refusing to hire persons who are at a clearly identified increased risk: namely, current smokers?
While it may be legal, that does not mean it is right. While it may be economically justifiable, that does not mean it is justified. And while it may make sense to tobacco control advocates to support such policies, that does not mean that it is sensible from a public health perspective.
There are three lines of analysis that I think are essential here:
First, one must consider what factors appropriately play into a decision about employment policies. Some have argued that economic factors are predominant: i.e., if smokers carry with them increased employer costs, then it is justified to not hire them, or to fire them if they are already employed and refuse to (or are unable to) quit. But I do not view employment decisions as being strictly economic ones. There are a host of factors that can and should play into these decisions, including not only economic impacts, but social factors as well, such as the potential impact on smokers as a social class if smoking comes to be synonymous with unemployability.
This is, I think, a serious concern. It will only take a few large employers to adopt such policies before smokers begin to feel the impact in terms of the employment choices that are available to them. And unfortunately, because smoking tends to be somewhat associated with lower income and highly associated with lower levels of education, this does become an issue of social class.
Further, one must consider the question of what other employment restrictions could be justified on similar economic grounds. Suicide has been shown to be associated with unwanted pregnancies and with having a family member who has committed suicide, but does that justify refusing to hire anyone who has ever had an unwanted pregnancy or who has ever had a family member commit suicide?
Second, one must consider what are the potential approaches to the problem? Certainly refusing to hire smokers is one of them. But isn't another approach to hire people on the basis of factors that are directly relevant to their job performance and then to implement employee assistance programs that work with employees to address factors such as smoking, physical health, and mental and emotional health and well-being? From a public health perspective, this second approach is far more sensible, compassionate, and defensible.
Third, I think it is important to note that these concerns apply equally well to problems such as attrition and absenteeism as they do to the issue of suicide risk. There really isn't much of a qualitative difference: absenteeism is a sort of partial attrition and suicide is basically complete and irreversible attrition. All the above arguments still hold with respect to economic concerns regarding employee absenteeism and attrition.
Finally, I should reiterate that I am not suggesting that it is inappropriate for employers to consider smoking as a factor in employment decisions when the smoking directly affects job performance or is inconsistent with a company mission. But I am suggesting that absent those concerns, if it is simply an issue of increased economic costs to the employer, I do not think it is sensible, compassionate, or justifiable for public health practitioners to support policies that make it more difficult for smokers to be employed in our society.
Subscribe to:
Posts (Atom)